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1. PUBLIC HEALTH STATEMENT 
This Statement was prepared to give you information about 2-butanone(methyl
ethyl ketone) and to emphasize the human health effects that may result from
exposure to it. The Environmental Protection Agency (EPA) has identified 1,177
sites on its National Priorities List (NPL). 2-butanone has been found at 137 of
these sites. However, we do not know how many of the 1,177 NPL sites have been
evaluated for 2-butanone. As EPA evaluates more sites, the number of sites at
which 2-butanone is found may change. The information is important for you because
2-butanone may cause harmful health effects and because these sites are potential
or actual sources of human exposure to 2-butanone. 
When a chemical is released from a large area, such as an industrial plant,
or from a container, such as a drum or bottle, it enters the environment as a
chemical emission. This emission, which is also called a release, does not always
lead to exposure. You are exposed to a chemical only when you come into contact
with the chemical. You may be exposed to it in the environment by breathing,
eating, or drinking substances containing the chemical or from skin contact with
it. 
If you are exposed to a hazardous substance such as 2-butanone, several
factors will determine whether harmful health effects will occur and what the type
and severity of those health effects will be. These factors include the dose (how
much), the duration (how long), the route or pathway by which you are exposed
(breathing, eating, drinking, or skin contact), the other chemicals to which you
are exposed, and your individual characteristics such as age, sex, nutritional
status, family traits, life style, and state of health. 
1.1 WHAT IS 2-BUTANONE? 
2-Butanone, also known as methyl ethyl ketone (MEK), is a colorless liquid
with a sweet, but sharp odor. 2-Butanone is manufactured in large amounts for use
in paints, glues, and other finishes because it rapidly evaporates and will
dissolve many substances, It will quickly evaporate into the air. 2-Butanone is
often found dissolved in water or as a gas in the air. 2-Butanone is also a 
natural product made by some trees and is found in some fruits and vegetables. The
exhausts of cars and trucks release 2-butanone into the air. 2-Butanone is usually
found in the air, water, and soil of landfills and hazardous waste sites. 
In water, 2-butanone can be changed to a more simple chemical form by natural
biological processes and will be broken down in about 2 weeks. It will not be
deposited in the sediment of rivers or lakes, and it is not expected to concentrate
in fish. In air, 2-butanone will break down under the influence of sunlight,
although it does not react with sunlight directly. One-half of any given amount of
2-butanone in the air will break down in 1 day or less. It is not known if 2­
butanone changes to a more simple form by 
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natural biological processes in soil, but it is expected to do so because
similar substances are broken down by these processes. 2-Butanone will not
stick to soil, and if it is spilled onto soil, it will travel through the
soil into underground water sources. Some of the 2-butanone found in soil
or water will also evaporate to the air. 
You will find more information on the chemical properties of 2­
butanone in Chapter 3. The uses of 2-butanone are given in Chapter 4. More
information on how 2-butanone behaves in the environment is found in 
Chapter 5. 
1.2 HOW MIGHT I BE EXPOSED TO 2-BUTANONE? 
2-Butanone can enter the environment in a number of different ways.
It can enter the air or water from the waste of manufacturing plants. 2­
Butanone is present in many different types of paints and glues used both
in the home and in industry. As these products dry, 2-butanone will enter
the air. 2-Butanone is also in air because it is released in the exhaust 
of cars and trucks. Some trees in the forest release 2-butanone to the 
air. 
We do not know the background levels of 2-butanone in air, water, or
soil. We know that 2-butanone is found naturally in some foods. We know 
it is found at hazardous waste sites, and it is also found occasionally in
drinking water and often in the air of cities. You may also be exposed to
2-butanone by smoking cigarettes. 
You may be exposed to higher levels of 2-butanone if you use glues of
coatings containing it in a small enclosed area that does not have good air
flow, People who use it at work have a good chance of being exposed to 2­
butanone. 2-butanone is used in such industries as shoes factories, printing
plants, plastics factories, and sporting goods manufacturers. People who live
near a toxic waste site where 2-butanone is kept may breathe it if it
evaporates into the air, or drink it if it gets into the water supply,
especially when the water supply comes from wells. 
You can find more information on how much 2-butanone is in the 
environment and how you can be exposed to it in Chapter 5. 
1.3 HOW CAN 2-BUTANONE ENTER AND LEAVE MY BODY? 
2-butanone can enter your body if you breathe air that contains it, through
your skin if it touches you, or through your mouth if you eat food or drink water
that has 2-butanone in it. Studies have shown that, if there is 2-butanone in the
air you breathe, at least half of what you breathe in will enter your body. The
other half will leave in the air you breathe out. We do not know how much
2-butanone will stay in your body if you drink it or if it touches your skin. The
amount of 2-butanone that actually enters your body depends on how much is in the
air you breathe, how much is in your food or 
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water, or how much gets on your skin. The amount of 2-butanone that enters your body
also depends on how long you breathe it or how long it is on your skin before you wash
it off. Your body gets rid of 2-butanone in urine and in the air you breathe out. 2­
Butanone is not a chemical that stays in your body for very long; it will be gone by
the next day. For more information on how 2-butanone gets into and leaves your body,
see Chapter 2. 
1.4 HOW CAN 2-BUTANONE AFFECT MY HEALTH? 
Some people who breathed air that contained 2-butanone first noticed its sweet,
sharp odor at a concentration of 5-8 parts of 2-butanone per million parts of air (5-8
ppm). The main health effects that have been seen in humans who breathed higher
concentrations of 2-butanone are mild irritation of the nose, throat, eyes, and skin. 
Serious health effects in animals have been seen only at very high
concentrations of 2-butanone. These high concentrations are not expected in the usual
use of 2-butanone or in the vicinity of hazardous waste sites. Studies in animals 
have shown that 2-butanone does not cause serious damage to the nervous system or the
liver, but mice that breathed low levels for a short time had temporary behavioral
effects. 2-Butanone alone does not have serious effects on the liver or nervous 
system, but it can cause other chemicals to become more harmful to these systems. 
Guinea pigs, rats, and mice that breathed high levels of 2-butanone for a short
time became unconscious and died. Pregnant rats and mice that breathed air containing
high levels of 2-butanone had underdeveloped fetuses. The rats that swallowed very
high concentrations of 2-butanone in water also developed signs of nervous system
effects such as inactivity, drooping eye lids, and uncoordinated muscle movement. Some
rats and mice that swallowed water containing high concentrations of 2-butanone died.
Rats that received water containing a lower concentration of 2-butanone had mild
kidney damage. Skin irritation developed in rabbits and guinea pigs that had small
amounts of 2-butanone dropped on their skin. Rabbits that had small amounts of 2­
butanone dropped in their eyes had serious eye irritation. We do not know whether 2­
butanone causes birth defects or affects reproduction in humans. Reproductive effects
were not seen in animals exposed to 2-butanone. We have no information about whether
2-butanone causes cancer in humans or animals. 
A more complete discussion of the health effects of 2-butanone in humans and
animals can be found in Chapter 2. 
1.5 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO 2-BUTANONE? 
No specific medical test is available to determine whether you have been exposed
to 2-butanone. Studies in humans and animals have shown that it is possible to detect
2-butanone or its breakdown products in the blood, breath, 
4 
1. PUBLIC HEALTH STATEMENT 
and urine. The levels of 2-butanone found in the blood, breath, and urine
are usually associated with the levels of exposure found in the workplace,
but this is more useful for determining exposure of groups of people
rather than individuals. Tests for 2-butanone in blood, urine, or breath
are useful only for recent exposure because 2-butanone and its breakdown
products leave the body rapidly. These considerations are discussed in
more detail in Chapters 2 and 6. 
1.6 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN HEALTH? 
The Occupational Safety and Health Administration (OSHA) has set an
occupational exposure limit of 200 ppm of 2-butanone in the air. The
National Institute for Occupational Safety and Health (NIOSH) has also
recommended 200 ppm of 2-butanone as the limit for up to a 10-hour work
shift in a 40-hour workweek. Because of its odor, you can smell 2-butanone
before it harms you. Further information on governmental recommendations
can be found in Chapter 7. 
1.7 WHERE CAN I GET MORE INFORMATION? 
If you have any more questions or concerns not covered here, please
contact your state health or environmental department or: 
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road, E-29
Atlanta, Georgia 30333 
This agency can also provide you with information on the location of
the nearest occupational and environmental health clinic. Such clinics
specialize in recognizing, evaluating, and treating illnesses that result
from exposure to hazardous substances. 
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2.1 INTRODUCTION 
The primary purpose of this chapter is to provide public health
officials, physicians, toxicologists, and other interested individuals and
groups with an overall perspective of the toxicology of 2-butanone (methyl
ethyl ketone) and a depiction of significant exposure levels associated
with various adverse health effects. It contains descriptions and
evaluations of studies and presents levels of significant exposure for 2­
butanone based on toxicological studies and epidemiological
investigations.
 2-Butanone alone is a relatively safe chemical widely used as a
insolvent industry. For some uses, 2-butanone is combined with other
chemicals thathave serious neurotoxic and hepatotoxic effects. Clinical
reports and animal studies have clearly shown that exposure to 2-butanone
alone causes minimal chronic neurological or hepatic deficits, if any. It
does potentiate both the neurotoxicity of n-hexane and methyl-n-butyl
ketone and the hepatotoxicity of carbon tetrachloride and chloroform. The
potentiation of neurotoxicity and hepatotoxicity by 2-butanone is
discussed in Section 2.6 (Interactions with other Chemicals). 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
To help public health professionals address the needs of persons
living or working near hazardous waste sites, the information in this
section is organized first by route of exposure--inhalation, oral, and
dermal--and then by health effect--death, systemic, immunological,
neurological, developmental, reproductive, genotoxic, and carcinogenic
effects. These data are discussed in terms of three exposure periods-­
acute (less than 15 days), intermediate (15-364 days), and chronic (365
days or more). 
Levels of significant exposure for each route and duration are presented in
tables and illustrated in figures. The points in the figures showing no-observed­
adverse-effect levels (NOAELS) or lowest-observed-adverse-effect levels (LOAELS)
reflect the actual doses (levels of exposure) used in the studies. LOAELs have been
classified into "less serious" or "serious" effects. These distinctions are 
intended to help the users of the document identify the levels of exposure at which
adverse health effects start to appear. They should also help to determine whether
or not the effects vary with dose and/or duration, and place into perspective the
possible significance of these effects to human health. 
The significance of the exposure levels shown in the tables and figures may
differ depending on the user's perspective. For example, physicians concerned with
the interpretation of clinical findings in exposed persons may be interested in
levels of exposure associated with "serious" effects. Public health officials and
project managers concerned with appropriate actions to take at hazardous waste
sites may want information on levels of exposure associated with more subtle
effects in humans or animals (LOAEL) or exposure 
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levels below which no adverse effects (NOAEL) have been observed.
Estimates of levels posing minimal risk to humans (minimal risk levels,
MRLs) may be of interest to health professionals and citizens alike.
 Estimates of exposure levels posing minimal risk to humans (MRLs)
have been made, where data were believed reliable, for the most sensitive
noncancer effect for each exposure duration. MRLs include adjustments to
reflect human variability from laboratory animal data to humans.
 Although methods have been established to derive these levels (Barnes et al.
1988; EPA 1989a), uncertainties are associated with these techniques. Furthermore,
ATSDR acknowledges additional uncertainties inherent in the application of the
procedures to derive less than lifetime MRLs. As an example, acute inhalation MRLs
may not be protective for health effects that are delayed in development or are
acquired following repeated acute insults, such as hypersensitivity reactions,
asthma, or chronic bronchitis. As these kinds of health effects data become
available and methods to assess levels of significant human exposure improve, these
MRLs will be revised. 
2.2.1 Inhalation Exposure 
2.2.1.1 Death 
No studies were located regarding death of humans following
inhalation exposure to 2-butanone.
 Acute (4-hour) exposure to 2,000 ppm 2-butanone caused the death of up to 4
of 6 rats within a 14-day observation period after exposure (Carpenter et al.
1949). The cause of death was not reported, but gross necropsy and histopathology
confirmed that extraneous infections were not involved. In contrast, exposure of 6
rats to 8,000 ppm 2-butanone for 8 hours resulted in the death of half of the rats
(Smyth et al. 1962). Furthermore, the 4-hour LC50 in rats, calculated from the dose-
response curve, was 11,700 ppm (LaBelle and Brieger 1955). The LC50 was determined 
using similar rats and the same exposure methods used by Carpenter et al. (1949).
Mice exposed to a saturated vapor of 2-butanone (estimated concentration: 103,000
ppm) showed a mean survival time of 43 minutes (LaBelle and Brieger 1955). The LT50 
and LT50 in rats exposed to 92,239 ppm 2-butanone were 3 and 0.5 hours, respectively
(Klimisch 1988). The LT50 represents the time of exposure after which 50% of the
animals died within 14 days following exposure. The LT0 represents the time of
exposure after which no animals died within 14 days following exposure. No deaths
were reported after a 4-hour exposure of mice to 2,438 ppm 2-butanone (De Ceaurriz
et al. 1983). Death of guinea pigs occurred within 45 minutes of exposure to
100,000 ppm 2-butanone and within 200 minutes of exposure to 33,000 ppm (Patty et
al. 1935). Gasping respiration was observed at concentrations of 33,000 ppm and
higher about 10 minutes before the guinea pigs died. 
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In intermediate duration studies, no deaths occurred during a 90-day exposure
of rats to 5,000 ppm or less, 5 days/week for 6 hours/day (Cavenderet al. 1983). In
contrast, five of five rats died within 7 weeks of a planned 15-week exposure to
6,000 ppm, 7 days/week, 8 hours/day (Altenkirch et al. 1978a). The cause of death
for all rats exposed to 2-butanone in this study was severe bronchopneumonia
confirmed pathologically and histologically. In the same study, rats exposed to n-
hexane or a combination of n hexane and 2-butanone did not develop
bronchopneumonia. A repeat of this study gave the same results, i.e., death within
7 weeks coincident with confirmed bronchopneumonia (Altenkirch et al. 1978b). Saida
et al. (1976) reported no deaths or change in clinical signs in rats exposed to
1,125 ppm 2-butanone continuously for 5 months. Similar results were reported by
several groups after intermediate exposures ranging from 200 to 800 ppm in rats and
guinea pigs, i.e., no deaths and no change in clinical signs (LaBelle and Brieger
1955; Takeuchi et al. 1983; Toftgard et al. 1981). The LC50 the highest NOAEL
values, and all reliable LOAEL values for death in each species and duration
category are recorded in Table 2-l and plotted in Figure 2-l. 
2.2.1.2 Systemic Effects 
The systemic effects of 2-butanone following inhalation exposure are
discussed below. No studies were located regarding cardiovascular,
gastrointestinal, musculoskeletal, hepatic, or renal effects in humans after
inhalation exposure to 2-butanone. The highest NOAEL values and all reliable LOAEL
values for each systemic effect for each species and duration category are recorded
in Table 2-l and plotted in Figure 2-l. 
Respiratory Effects. 2-Butanone is irritating to respiratory tissues. A
clinical case report of three men exposed to 2-butanone fumes while removing paint
from an airplane hangar noted mild respiratory symptoms but did not further
describe the nature or extent of the symptoms (Berg 1971). Volunteers exposed to
100 ppm 2-butanone complained of slight nose and throat irritation, which became
objectionable at 300 ppm (Nelson et al. 1943). The respiratory tract irritation
noted in humans at 100 ppm does not imply that humans are more sensitive to the
respiratory effects of 2-butanone than other species tested (see Table 2-l).
Another possible explanation is that humans are better able to communicate the 
early signs of irritation compared with the other species tested. Nasal resistance
was significantly increased in humans upon exposure to the threshold level of 2­
butanone; this response reflects a nasopharyngeal reflex (Doty et al. 1988). The 
odor threshold for 2-butanone falls in the range 5.4-8.25 ppm (Amoore and Hautala
1983; Doty et al. 1988). 
At high concentrations, 2-butanone is also irritating to respiratory tissues
of animals. Severe upper respiratory tract irritation was found after a few days in
rats exposed to 10,000 ppm, 8 hours/day (Altenkirch et al. 1978a). Guinea pigs
exposed to 33,000 ppm had gasping respiration after 180 minutes of exposure and
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lungs were emphysematous. Rats seem to tolerate concentrations that are still high,
but substantially lower than the acute exposures when exposed intermittently in
intermediate duration studies. In a 90-day inhalation study, exposure of rats to 2­
butanone concentrations of 5,000 ppm or less caused no signs of upper respiratory
tract irritation or other respiratory effects (Cavender et al. 1983). Due to the
irritation observed at 10,000 ppm in the study by Altenkirch et al. (1978a), the
exposure concentration was reduced to 6,000 ppm and the study continued. All the
rats died suddenly at 7 weeks with pathologically confirmed bronchopneumonia. This
experiment was repeated and had the same results (Altenkirch et al. 1978b).
Furthermore, rats exposed to n-hexane or a combination of n-hexane and 2-butanone
did not develop bronchopneumonia, suggesting that a factor other than poor animal
maintenance precipitated the bronchopneumonia. The Wistar rats used in this study
may possibly have been derived from a stock that was particularly susceptible to
infection. The initial exposure to a high concentration of 2-butanone may have
weakened their immune system allowing infection to develop. No other studies were
located that reported a link between 2-butanone exposure and bronchopneumonia in
humans or animals. 
Cardiovascular Effects. No studies were located regarding cardiovascular
effects in humans after inhalation exposure to 2-butanone. 
Histological examination of the hearts and aortae of rats exposed to 5,000
ppm or less of 2-butanone for 90 days revealed no exposure-related lesions
(Cavender and Casey 1981; Cavender et al. 1983). 
Gastrointestinal Effects. No studies were located regarding gastrointestinal
effects in humans after inhalation exposure to 2-butanone. 
No histopathological lesions were found in the esophagus, salivary glands,
ileum, duodenum, jejunum, cecum, large or small intestines, or pancreas of rats
exposed to 5,000 ppm or less of 2-butanone for 90 days(Cavender and Casey 1981;
Cavender et al.1983). 
Hematological Effects. Information regarding hematological effects of 2­
butanone exposure in humans is limited to a case report in which a normal
hematological profile and blood chemistry were found in an 18-year-old seaman
exposed to 2-butanone while removing paint from an airplane hangar (Berg 1971). 2­
Butanone exposure in this case was linked to retrobulbar neuritis and severely
impaired vision. However, because methanol was found in the blood of the patient,
consumption or exposure to methanol cannot be ruled out.
 Studies in animals also indicate that 2-butanone does not produce
hematological effects. No effect on hemoglobin concentration, or on red blood cell,
white blood cell, neutrophil, lymphocyte, or monocyte populations were observed in
rats exposed intermittently to 235 ppm 2-butanone for 12 weeks(LaBelle and Brieger
1955). Similarly, the hematological profile and serum 
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chemistry of rats exposed to 5,000 ppm or less of 2-butanone for 90 days
were normal (Cavender et al. 1983). 
Musculoskeletal Effects. No studies were located regarding musculoskeletal
effects in humans after inhalation exposure to 2-butanone. 
Histological examination of skeletal muscle and bone of rats exposed to 5,000
ppm or less of 2-butanone for 90 days revealed no exposure-related lesions
(Cavender and Casey 1981; Cavender et al. 1983). 
Hepatic Effects. No studies were located regarding hepatic effects in
humans after inhalation exposure to 2-butanone. 
Most of the hepatic effects of inhalation exposure to 2-butanone observed in
animals are minimal and probably not adverse, although acute exposure of guinea
pigs to a high concentration (10,000 ppm) caused liver congestion (Patty et al.
1935). Exposure to 3,300 ppm had no effects. Serum alkaline phosphatase activity
was not different in rats exposed intermittently to 300 ppm 2-butanone for 7 days
compared to nonexposed control rats (Li et al. 1986). There was no change in the
isozymes of cytochrome P-450 or in the total concentration of cytochrome P-450 in
rats exposed to 800 ppm for 4 weeks(Toftgard et al. 1981). 2-Butanone, however,
altered the metabolism of androstenedione by increasing the formation of two
metabolites and decreasing the formation of two other metabolites. Furthermore,
liver weight was increased in the 2-butanone-exposed rats (Toftgard et al. 1981). A
small but statistically significant increase in absolute and relative liver weights
of male and female rats, but no change in serum levels of hepatic enzymes (serum
glutamic-oxaloacetic transaminase [SGOT], serum glutamic-pyruvic
transaminase[SGPT], serum gamma-glutamyl transpeptidase [SGGT], and alkaline
phosphatase)in male rats, was observed at an exposure level of 5,000 ppm for 90
days (Cavender et al. 1983). A significant increase only in alkaline phosphatase
was noted in the female rats. Histopathological examination did not reveal any
hepatic lesion aside from those expected in Fischer rats of this age. Exposure to
2,500 ppm 2-butanone had no effect on any hepatic parameter (Cavender et al. 1983).
In the absence of histopathological liver lesions, the mild liver effects observed
at 5,000 ppm were probably not adverse. 
Renal Effects. No studies were located regarding renal effects in humans
following inhalation exposure to 2-butanone. 
Acute inhalation exposure of guinea pigs to 10,000 ppm 2-butanone
resulted in congestion of the kidney (Patty et al. 1935). No effects were
observed at 3,300 ppm. In an intermediate duration study, only minimal
kidney effects were observed in rats exposed to 5,000 ppm or less
(Cavender et al. 1983). Blood urea nitrogen determinations and urinalysis
including urine volume, specific gravity, and pH showed that all values
were within normal limits for male and female rats; the exception was that
urine volume in the females was slightly but significantly increased. The
kidney/body weight 
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ratio in male rats and the kidney/brain weight ratio in female rats were
slightly but significantly elevated. Histopathological examination did not
reveal any treatment-related renal lesion. In the absence of histopathological
lesions or decrements in kidney function, these mild kidney effects do not
appear to be adverse. No other studies were located regarding the renal effects
of inhalation exposure to 2-butanone. 
Dermal/Ocular Effects. Two men exposed to 2-butanone while removing paint
from an airplane hangar had conjunctival irritation (Berg 1971). A
third man had severe loss of vision. Within 36 hours, the man's vision was
completely restored. However, because methanol was found in the blood of the
man with vision loss, exposure to methanol cannot be ruled out. No other
studies were located regarding dermal/ocular effects in humans following
inhalation exposure to 2-butanone. 
Guinea pigs exposed to 2-butanone. concentrations of 10,000 ppm or
greater had eye irritation and lacrimation (Patty et al. 1935). Exposure to
100,000 ppm for 30 minutes or more caused cornea1 opacity. This condition
gradually improved in guinea pigs that lived to 8 days after exposure. No
effects occurred when guinea pigs were exposed to 3,300 ppm. Ophthalmological
examination of the eyes and histological examination of the skin revealed no
effects in rats exposed to 5,000 ppm or less of 2-butanone for 90 days
(Cavender and Casey 1981; Cavender et al. 1983). No other studieswere
located regarding dermal/ocular effects in animals following inhalation
exposure to 2-butanone. 
Other Systemic Effects. No studies were located regarding other systemic
effects in humans after inhalation exposure to 2 butanone. 
In rats, no histopathological lesions were found in the thyroid,
parathyroid, pituitary gland, adrenal glands, ears, or Zymbal glands
of rats exposed to 5,000 ppm or less of 2-butanone for 90 days
(Cavender and Casey 1981; Cavender et al. 1983). Furthermore, no
specific effects on body weight were found. 
2.2.1.3 Immunological Effects 
No studies were located regarding immunological effects in humans
following inhalation exposure to 2-butanone. 
Although no specific tests for immunological effects were
performed, histological examination of lymph nodes, thymus, spleen,
and bone marrow of rats exposed to 5,000 ppm or less of 2-butanone for
90 days revealed no exposure-related lesions (Cavender and Casey 1981;
Cavender et al. 1983). This NOAEL value is recorded in Table 2-l and
plotted in Figure 2-l.
,’ 
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2.2.1.4 Neurological Effects 
In three separate studies, volunteers underwent a single 4-hour
exposure to 200 ppm 2-butanone (Dick et al. 1984, 1988, 1989). No
differences were observed between exposed and control groups on
neurobehavioral tests including psychomotor tests (choice reaction time,
visual vigilance, dual task, and memory scanning), postural sway, and a
profile of mood states. No other studies were located regarding
neurological effects after inhalation exposure to 2-butanone. 
Neurological effects have been observed in animals exposed by inhalation to
2-butanone. Exposure of mice to 2-butanone at concentrations greater than or equal
to 1,602 ppm for 4 hours caused a dose-related reduction in the duration of
immobility in a "behavioral despair" swimming test (De Ceaurriz et al. 1983). The
authors noted that the effect of 2-butanone was similar to that of antidepressants.
In guinea pigs exposed acutely to 10,000 ppm 2-butanone, incoordination occurred
within 90 minutes and unconsciousness occurred within 240-280 minutes (Patty et al.
1935). These signs occurred earlier at higher concentrations, but no neurological
signs were observed at 3,300 ppm. Juvenile baboons exposed continuously to 100 ppm
for 7 days showed early signs of narcosis, incoordination, and a loss of time
perception in neurobehavioral tests (Geller et al. 1979). The neurological effects
observed in this study could have resulted from narcosis. It is also possible that
the baboons were distracted during the testing due to the irritating effects of 2­
butanone on the respiratory system. Furthermore, the effects of 2-butanone observed
at 100 ppm in the baboons do not imply that baboons are more sensitive to 2­
butanone than other species tested. Since the baboons were evaluated with a complex
discriminant behavioral task, it is possible that subtle neurobehavioral effects
could be observed. However, it should be noted that only one exposure level was
tested, only one baboon of four tested showed consistently different results from
the controls throughout the study, and no statistical tests were performed. These
limitations preclude definitive conclusions. 
Intermediate duration exposures to 2-butanone were not neurotoxic in rats.
Male Sprague-Dawley rats exposed continuously to 1,125 ppm 2-butanone for periods
of 5 months or less showed no signs of peripheral neuropathy following histological
examination (Saida et al. 1976). The neurotoxicity of n-butyl ketone, however, was
markedly potentiated by 2-butanone. No differences were observed in nerve fiber
preparations from male and female Fischer 344 rats exposed to 5,000 ppm or less 2­
butanone for 90 days (Cavender and Casey 1981; Cavender et al. 1983). Furthermore,
no histopathological lesions were found in the brain, sciatic nerve, tibia1 nerve,
spinal cord, or optic nerves. No effects were observed in posture, gait, tone, and
symmetry of the facial muscles, or in the pupillary, palpebral, extensor thrust,
and cross-extensor thrust reflexes. The only effect recorded was a slight but
statistically significant increase in brain weight in female rats exposed to 5,000
ppm. No clinical signs and no histological evidence of neuropathy in 
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peripheral nerves from the brachial plexus, sciatic nerve, spinal cord, and medulla
were observed in rats exposed to 6,000 ppm for 7 weeks compared with rats exposed
to n-hexane or a combination of n-hexane and 2-butanone(Altenkirch et al. 1978a).
In contrast, 2-butanone potentiated the neurotoxicity of n-hexane. No
neuropathological changes were found on light microscope and electron microscope
examination of teased tail nerves after exposure of a rat to 200 ppm 2-butanone for
24 weeks (Takeuchi et al. 1983). At 4 weeks, significant increases in motor nerve
conduction velocity and mixed nerve conduction velocity were found, while distal
motor latency was decreased. These changes in nerve conduction velocity were not
seen beyond 4 weeks. The transient increase in nerve conduction velocity may have
been due to an effect of 2-butanone on the axonal membrane (Takeuchi et al. 1983).
The highest NOAEL values and all reliable LOAEL values for neurological
effects in each species and duration category are recorded in Table 2-l
and plotted in Figure 2-l. 
2.2.1.5 Developmental Effects 
No studies were located regarding developmental effects in humans
after inhalation exposure to 2-butanone. 
Several studies in rats and mice were located regarding developmental effects
after inhalation exposure. Exposure of pregnant rats to 1,000 or 3,000 ppm 2­
butanone during gestation resulted in a slight increase in the incidence of
malformations at 3,000 ppm; acaudia and imperforate anus were found in 2 fetuses
out of 21 litters, and brachygnathia was noted in 2 other fetuses (Schwetz et al.
1974). A low incidence of sternebral anomalies was also noted in the 3,000 ppm
group. Although the incidence of malformations was not high enough to support a
positive correlation, it may have indicated a slight teratogenic effect in rats. A
second study by the same group supported the previous findings of skeletal
anomalies (Deacon et al. 1981). No statistically significant differences in
external or soft tissue abnormalities were found in the offspring of dams exposed
to 3,000 ppm or less during gestation, No effect was observed on the number of live
fetuses/litter or on fetal crown-rump length. Skeletal abnormalities, including
delayed ossification of the cervical centra, sternebral malformations, and
asymmetric pelvis were observed at 3,000 ppm. Decreased body weight gain and
increased water consumption in the pregnant rats at 3,000 ppm 2-butanone indicated
that some maternal toxicity may have occurred at this exposure level. Deacon et al.
(1981) concluded 2-butanone was slightly fetotoxic, but not embryotoxic or
teratogenic at 3,000 ppm. Mean fetal body weight was reduced in the male and female
offspring of mouse dams exposed to 3,000 ppm butanone, but was significantly
reduced only in the males(Mast et al. 1989). A statistically significant increase
in the incidence of misaligned sternebrae was observed in the 3,000 ppm group. No
effects were observed at 1,000 ppm. Thus, 2-butanone was fetotoxic in both rats and
mice. In pregnant rats, continuous exposure to 800 ppm 2-butanone throughout
gestation resulted in the failure of three of eight of the rats to deliver 
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litters. While all 8 of the control dams in the experiment for 2-butanone delivered
litters, 6 of 16 control dams in an experiment with n-hexane in the same study also
failed to produce litters. Therefore, the reliability of the results in the 2­
butanone exposed group is questionable (Stoltenburg-Didinger et al. 1990). The
reliable NOAEL and LOAEL values for developmental effects are recorded in Table 2-l
and plotted in Figure 2-l. 
2.2.1.6 Reproductive Effects 
No studies were located regarding reproductive effects in humans
after inhalation exposure to 2-butanone. 
Although no tests for reproductive function were performed, histological
examination of the testes, epididymides, seminal vesicles, vaginas, cervices,
uteri, oviducts, ovaries, or mammary glands of rats exposed to 5,000 ppm or less
of 2-butanone for 90 days revealed no exposure-related lesions (Cavender and Casey
1981; Cavender et al. 1983). 
2.2.1.7 Genotoxic Effects 
No studies were located regarding genotoxic effects in humans or
animals after inhalation exposure to 2-butanone. 
Genotoxicity studies are discussed in Section 2.4. 
2.2.1.8 Cancer 
Two retrospective studies of industrial workers chronically exposed to 2­
butanone in dewaxing plants reported that deaths due to cancer were less than
expected. In a cohort of 446 males employed by Shell Chemical Company, 13 deaths
were due to cancer, whereas 14.26 were expected; the standard mortality ratio
(SMR) was 0.91 (Alderson and Rattan 1980). In the same cohort, 2 cases of buccal
or pharyngeal neoplasms were found; 0.13 were expected to exist, and the' SMR was
15.38. There were 4 cases of stomach, colon, or rectal cancer; 3.18 were expected,
and the SMR was 1.28. The incidence of buccal or pharyngeal neoplasms was
statistically significant but was regarded by the authors as due to chance because
of the small number of individuals affected and the number of separate comparisons
made between observed and expected rates. Furthermore, the use of tobacco was not
discussed in this study. The incidence of stomach, colon, or rectal cancer was not
statistically significant. The authors concluded that there was no clear evidence
of a cancer hazard at this dewaxing plant. A retrospective cohort study of 1,008
male oil refinery workers occupationally exposed to an estimated l-4 ppm of 2­
butanone in a dewaxing-lubricating oil plant was also conducted (Wen et al. 1985).
The overall cancer-related mortality was less than expected. The increased
incidence of buccal and pharyngeal neoplasms reported by Alderson and Rattan
(1980) was not confirmed in this study. 
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No studies were located regarding cancer in animals following
inhalation exposure to 2-butanone. 
2.2.2 Oral Exposure 
2.2.2.1 Death 
No studies were located regarding death of humans following oral
exposure to 2-butanone. 
Oral LD50 values for 2-butanone were similar (approximately 2,737
mg/kg) in three groups of Sprague-Dawley rats: immature (14 days old),
young adult(80-160 g), and older adult (300-470 g) (Kimura et al.
1971). The oral LD50 could not be determined in newborn rats because of 
volume limitations; it was estimated to be less than 805 mg/kg, Most
of the Sprague-Dawley rats receiving 3,670, 7,340, or 14,680 mg/kg by
gavage died within 1 hour at each dose, except 1 male and 1 female at
the lowest dose; these rats survived until sacrifice at 14 days
(Stillmeadow Inc. 1978). The data were insufficient for determination
of an LD50, but the authors estimated the acute oral LD50 to be less 
than 3,670 mg/kg, which is in agreement with the data reported in
Kimura et al. (1971). The LD50 in Carworth-Wistar rats was 5,522 mg/kg
(Smyth et al. 1962), which may represent a strain difference. In two
separate experiments, 1,080 mg 2-butanone/kg administered by gavage in
corn oil produced no deaths in male Fischer rats (Brown and Hewitt
1984) or in male Sprague-Dawley rats(Hewitt et al. 1983). Tanii et al.
(1986) determined the oral LD50 for 2-butanone in mice as 4,044 mg/kg
(95% confidence limits - 3,200-5,111 mg/kg). The acute duration LD50 
values and the LOAEL value for death in rats are recorded in Table 2-2 
and plotted in Figure 2-2. 
2.2.2.2 Systemic Effects 
The systemic effects of 2-butanone after oral exposure are
discussed below. No studies were located regarding gastrointestinal,
hematological, musculoskeletal, or dermal/ocular effects in humans or
animals after oral exposure to 2-butanone. The highest NOAEL values
and all reliable LOAEL values for each systemic effect after oral
exposure in each species and duration category are recorded in Table
2-2 and plotted in Figure 2-2.
 Respiratory Effects. One clinical report of oral exposure to 2-butanone in
humans was located. A 47-year-old woman accidentally ingested an unknown volume of
2-butanone that had been stored in a rum bottle (Kopelman and Kalfayan 1983). She
was admitted to an emergency ward unconscious and hyperventilating. Blood gases
were 85 mmHg oxygen and 24 mmHg carbon dioxide. Analysis of her blood showed a 2­
butanone plasma concentration of 95 mg/lOO mL. Slow infusion of sodium bicarbonate
reduced the hyperventilation, and blood gases improved to 78 mmHg oxygen and 25
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uneventful recovery over the next few days, and was discharged after 1
week(Kopelman and Kalfayan 1983). 
All albino rats receiving 3,670 mg/kg or more had labored breathing, and
most of them died within 1 hour (Stillmeadow Inc. 1978). It is'not clear
whether the labored breathing represented a respiratory or a neurological
response to a high dose. No other studies were located regarding respiratory
effects after oral exposure to 2-butanone. 
Cardiovascular effects. Cardiovascular effects observed in a 47-year­
old woman after accidental ingestion of 2-butanone were decreased blood
pressure and increased pulse rate (Kopelman and Kalfayan 1983). No other
reports were located regarding cardiovascular effects in humans following oral
exposure to 2-butanone. 
No studies were located regarding cardiovascular effects in animals

following oral exposure to 2-butanone.
 
Hepatic Effects. No studies were located regarding hepatic effects
in humans following oral exposure to 2-butanone. 
2-Butanone had no effect on liver weight, SGPT, or serum ornithine
carbamyl transferase activities measured 42 hours after oral exposure of rats
to 1,080 mg/kg (Hewitt et al. 1983). Similarly, Brown and Hewitt (1984)observed
normal SGPT activity in rats exposed orally to 1,080 mg 2-butanone/kg. Although
histological examination was not performed, 2-butanone appears to have a low
order of hepatic toxicity in inhalation studies. Several studies have shown
that 2-butanone has the ability to induce microsomal liver enzymes. Acute oral
treatment of rats with 2-butanone at doses of 1,080 to 1,500 mg/kg/day for l-7
days resulted in increased levels of cytochrome P-450, increased activities of
cytochrome P-450-dependent monooxygenases (Brady et al. 1989; Raunio et al.
1990; Robertson et al. 1989; Traiger et al. 1989) and proliferation of the
smooth endoplasmic reticulum(Traiger et al. 1989). In the absence of clinical
or histological evidence of liver damage, induction of microsomal enzymes
probably represents a normal physiological response to xenobiotics rather than
an adverse effect. Furthermore, oral treatment of rats with 1,080 mg/kg
2-butanone had no effect on the fragility of hepatic lysosomes or on the
calcium uptake by mitochondria or microsomes (Hewitt et al. 1990). Therefore,
the doses of 1,080-1,500 mg/kg can be considered acute oral NOAEL values for
hepatic effects.
 Renal Effects. No studies were located regarding renal effects in humans
following oral exposure to 2-butanone.
 Oral exposure of rats to 1,080 mg 2-butanone/kg caused mild renal tubular
necrosis but had no effect on renal organic ion transport(PAH, TEA) or
plasmacreatinine (Brown and Hewitt 1984). No other studies were located
regardingrenal effects in animals after oral exposure to 2-butanone. 
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2.2.2.3 Immunological Effects
 No studies were located regarding immunological effects in humans or
animals after oral exposure to 2-butanone. 
2.2.2.4 Neurological Effects
 No studies were located regarding neurological effects in humans after
oral exposure to 2-butanone.
 In animals, clinical signs of central nervous system toxicity including
lethargy, labored breathing, ptosis, lacrimation, exophthalmos, ataxia,
salivation, and piloerection were observed in rats treated by gavage with
2-butanone at doses greater than or equal to 3,670 mg/kg (Stillmeadow Inc.1978).
Most of these rats died. No effect was observed on neurobehavioral tests 
including hindlimb grasp, hindlimb place, balance beam, and roto-rod in rats
treated by gavage with 2-butanone at a time-weighted average dose of 173
mg/kg/day for 90 days (Ralston et al. 1985). No other studies were located
regarding neurological effects in animals after oral exposure to 2-butanone. The
NOAEL value and LOAEL value for neurological effects are recorded in Table 2-2
and plotted in Figure 2-2. 
No studies were located regarding the following health effects in humans
or animals after oral exposure to 2-butanone: 
2.2.2.5 Developmental Effects
2.2.2.6 Reproductive Effects
2.2.2.7 Genotoxic Effects 
Genotoxicity studies are discussed in Section 2.4. 
2.2.2.8 Cancer 
No studies were located regarding cancer in humans or animals after oral
exposure to 2-butanone. 
2.2.3 Dermal Exposure 
2.2.3.1 Death 
No studies were located regarding death in humans after dermal exposure
to 2-butanone. One study reported the dermal LD50 for 2-butanone in rabbits to be 
greater than 10 mL/kg (Smyth et al. 1962). No other studies were located
regarding death in animals after dermal exposure to 2-butanone. 
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2.2.3.2 Systemic Effects 
No studies were located regarding respiratory, cardiovascular,
gastrointestinal, hematological, musculoskeletal, hepatic, or renal
effects in humans or animals after dermal exposure to 2-butanone. 
The only systemic effects of dermal exposure studied were dermal and
ocular. The highest NOAEL value and all reliable LOAEL values for dermal
and ocular effects in each species and duration category are recorded in
Table 2-3. 
Dermal/Ocular Effects. Application of 0.1 mL undiluted 2-butanone
once daily for 18 days to the volar forearm of volunteers did not result
in erythema, increase in skin-fold thickness, or edema over the 18-day
exposure period Wahlberg (1984). Further details regarding the number of
volunteers were not reported. 
In rabbits and guinea pigs, application of undiluted 2-butanone
caused minimal skin irritation, erythema, and/or increase in skin-fold
thickness (Anderson et al. 1986; Hazleton Laboratories 1963a; Wahlberg
1984). Slight desquamation occurred in guinea pigs after 31 weeks of
dermal exposure to increasing amounts of 2-butanone (Eastman Kodak 1978).
Abraded skin areas were slightly more sensitive to the application of 2­
butanone (Hazleton Laboratories 1963a). 
2-Butanone instilled into the conjunctival sac of rabbits caused
irritation, cornea1 opacity, and conjunctivitis (Davis and Baker 1975;
Haskell Laboratories 1971; Hazleton Laboratories 1963b; Kennah et al.
1989). These effects were generally reversible in 7-14 days. Hazleton
Laboratories (1963b) reported that one of six rabbits had persistent
cornea1 damage after 7 and 14 days. On the basis of Draize scores in these
studies, 2-butanone was classified as moderately irritating. 
2.2.3.3 Immunological Effects 
One clinical report of 2-butanone-evoked contact urticaria was
located. A 48-year-old man employed as a painter complained of severe
irritation when he handled 2-butanone (Varigos and Nurse 1986). A small
amount of 2-butanone applied to his forearm produced a bright red area at
the site of application. The area became itchy, but no induration or
edema was noted. After 15 minutes, the reaction subsided. Two days later,
the test was repeated with the same result. Five volunteers were later
tested for sensitivity to 2-butanone by the same method, but no response
was observed. 
No studies were located regarding immunological effects in animals
after dermal exposure to 2-butanone. 
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2.2.3.4 Neurological Effects 
No studies were located regarding neurological effects in humans
after dermal exposure to 2-butanone. 
In an intermediate study of dermal exposure, l-2 mL of undiluted 2­
butanone was applied in increasing amounts to shaved areas on the backs of
guinea pigs 5 days/week for 31 weeks or less (Eastman Kodak 1978). No
clinical signs of neurotoxicity were observed. No evidence of
neurotoxicity was noted on examination of Epon sections of the medulla
oblongata and tibia1 nerve by light microscopy (Eastman Kodak 1978). The
details of 2-butanone application, however, were not clear in this report. 
No studies were located regarding the following health effects in
humans or animals after dermal exposure to 2-butanone: 
2.2.3.5 Developmental Effects 
2.2.3.6 Reproductive Effects 
2.2.3.7 Genotoxic Effects 
Genotoxicity studies are discussed in Section 2-4. 
2.2.3.8 Cancer 
No studies were located regarding cancer in humans or animals after
dermal exposure to 2-butanone. 
2.3 TOXICOKINETICS 
2.3.1 Absorption 
2.3.1.1 Inhalation Exposure 
2-Butanone is well absorbed during inhalation exposure. Pulmonary
uptake in humans ranged from 41% to 56% of the inspired quantity (Liira et
al. 1988a, 1988b, 1990). Exercise increased the pulmonary uptake due to
the greater ventilatory rate (Liira et al. 1988b). The high blood/air
solubility ratio of 2-butanone also favors absorption (Saida et al. 1976;
Perbellini et al. 1984). Several investigators have reported that
exposure concentrations of Z-butanoneare significantly correlated with
blood concentrations in humans (Brown et al. 1986; Brugnone et al. 1983;
Ghittori et al. 1987; Liira et al. 1988a, 1988b;Lowry 1987; Miyasaka et
al. 1982; Perbellini et al. 1984; Tolos et al. 1987). Exposure of humans
to 200 ppm 2-butanone for 4 hours resulted in blood concentrations of 3.5­
7.2 µg/mL (Liira et al. 1988a, 1988b; Lowry 1987). Occupational
concentrations are significantly correlated with blood and urine
concentrations of unmetabolized 2-butanone (Brugnone et al. 1983; Ghittori
et al. 1987; Miyasaka et al. 1982). Blood levels of 2-butanone are also 
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significantly correlated with breath levels (Brown et al. 1986). These
data indicate that 2-butanone is absorbed upon inhalation.
 Information on the absorption of 2-butanone by animals after
inhalation exposure is limited. Rats that were exposed to 600 ppm 2­
butanone for 6 hours on 1 day or for 6-10 hours/day for 8 days had blood
concentrations of 1,041 µmol/L after a single exposure and 1,138 µmol/L
after repeated exposure(Liira et al. 1991). The similarity in blood
concentrations after single and repeated intermittent exposure indicates
that 2-butanone does not accumulate. 
2.3.1.2 Oral Exposure 
A woman who had metabolic acidosis after having accidentally
ingested 2-butanone stored in a rum bottle had a blood concentration of 95
mg/lOO mL(13.2 mM) (Kopelman and Kalfayan 1983). A man who intentionally
ingested 100 mL of liquid cement containing a mixture of acetone (18%), 2
butanone (28% or about 37 mg/kg), and cyclohexanone (39%) had a plasma
level of 2-butanone of about 110 µg/mL at 5 hours after ingestion (Sakata
et al. 1989). These reports provide qualitative evidence that 2-butanone
is absorbed following oral exposure in humans, but do not provide
information regarding the extent of absorption. In the first case, the
quantity ingested was unknown, while in the second case, the man was
treated by gastric lavage at 2 hours after ingestion.
 Oral administration (gavage) of 1,690 mg 2-butanone/kg in rats
resulted in a plasma concentration of 94 mg/lOO mL at 4 hours (Dietz and
Traiger 1979). Within 18 hours, the plasma concentration decreased to 6.2
mg/lOO mL (Dietzand Traiger 1979). A second, similar experiment in rats
showed that, after oral administration of 1,690 mg 2-butanone/kg, the
plasma concentration was 95 mg/lOO mL; the concentration decreased to 7
mg/lOO mL by 18 hours (Dietz et al. 1981). These data indicate that 2­
butanone is rapidly absorbed and eliminated after oral administration. 
2.3.1.3 Dermal Exposure 
No studies were located regarding the rate or extent of absorption
of 2-butanone in humans or animals following dermal exposure. 
2.3.2 Distribution 
2.3.2.1 Inhalation Exposure 
No studies were located regarding the distribution of 2-butanone
following inhalation exposure in humans.
 In vitro determinations of the 2-butanone tissue/air solubility ratio
for human kidney, liver, muscle, lung; heart, fat, and brain show that the
solubility is similar in all tissues, and that the ratio is nearly equal
to 
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200 (Perbellini et al. 1984). Blood/tissue solubility ratios are all near
unity; therefore, 2-butanone is not expected to concentrate in any one
tissue(Perbellini et al. 1984).
 Information regarding distribution of 2-butanone in animals after
inhalation exposure is limited. Rats that were exposed to 600 ppm
2-butanone for 6 hours on 1 day or for 6-10 hours/day for 8 days had blood
concentrations of 1,041 µmol/L after a single exposure and 1,138 µmol/L
after repeated exposure (Liira et al. 1991). The concentration of 2­
butanone in perirenal fat was 0.71 µmol/g after a single exposure and 0.70 
µmol/g after repeated exposure. The similarity in blood and perirenal
concentrations after single and repeated intermittent exposure indicates
that 2-butanone does not accumulate. 
2.3.2.2 Oral Exposure 
No studies were located regarding the distribution of 2-butanone
following oral exposure in humans or animals. 
2.3.2.3 Dermal Exposure 
No studies were located regarding the distribution of 2-butanone
following dermal exposure in humans or animals. 
2.3.3 Metabolism 
Few studies exist regarding the metabolism of 2-butanone in humans. Two
metabolites of 2-butanone have been identified in human urine after 
inhalation exposure. They are 3-hydroxy-2-butanone (Brugnone et al. 1983;
Perbellini et al. 1984) and 2,3-butanediol (Liira et al. 1988a, 1988b,
1990). The urinary concentrations of these metabolites, however, represent
only about 0.1%-2% of the absorbed 2-butanone. P-Butanol was found in the
blood of male volunteers exposed to 200 ppm 2-butanone for 4 hours (Liira
et al. 1990). In addition to 3-hydroxy-2-butanone and 2,3-butanediol, a
third metabolite, 2-butanol, has been found in the blood in guinea pigs
(DiVincenzo et al. 1976)and rats (Dietz et al. 1981). About 30% of the 2­
butanone administered orally in rats was converted to 2,3-butanediol; 4%
was converted to 2-butanol, and 4% was converted to 3-hydroxy-2-butanone
(Dietz et al. 1981). 
In guinea pigs, 2-butanone was metabolized by both oxidative and
reductive pathways (Figure 2-3). Oxidation produces 3-hydroxy-2-butanone,
which is then reduced to 2,3-butanediol (DiVincenzo et al. 1976).
Reduction of 2-butanone produces 2-butanol. The metabolites of 2-butanone
in guinea pigs were excreted in the urine as 0-glucuronides or O-sulfates. 
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2.3.4 Excretion 
2.3.4.1 Inhalation Exposure 
Urinary excretion of unchanged 2-butanone and its metabolites, 3­
hydroxy-2-butanone and 2,3-butanediol, accounts for only 5% or less of the
2-butanone absorbed by inhalation in humans (Liira et al. 1988a,
1990;Perbellini et al. 1984). Unchanged 2-butanone is excreted primarily
through the lungs; the quantity eliminated by this route is an estimated
20X-40% (Browning 1965; Riihimaki 1986); however, only about 3% of
absorbed 2-butanone was excreted unchanged in the expired air of humans
exposed to 200 ppm for 4 hours (Liira et al. 1988a, 1990). 2-Butanone is
rapidly cleared from the blood with a reported plasma half-life in humans
of 49-96 minutes (Brown et al. 1986; Liira et al. 1988a; Lowry 1987) and
an apparent clearance rate of 0.60 L/minute (Liira et al. 1990).
Therefore, 2-butanone would not be expected to accumulate with chronic
exposure (Lowry 1987).
 No studies were located regarding excretion of 2-butanone in
animals after inhalation exposure. 
2.3.4.2 Oral Exposure 
Information regarding the excretion of 2-butanone after oral
exposure in humans is limited. A man who intentionally ingested 100 mL of
liquid cement containing a mixture of acetone (18X), 2-butanone (28% or
about 37 mg/kg), and cyclohexanone (39%) had a plasma level of 2-butanone
of about 110 µg/mL at 5 hours after exposure (Sakata et al. 1989). The
plasma level declined to about 95 µg/mL at 12 hours and to <20 µg/mL at 18
hours, where it remained until about 25 hours and slowly declined to <5 
µg/mL at 48 hours. Urine levels of 2-butanone decreased gradually from 123 
µg/mL at 5 hours to 61 µg/mL at 19 hours. Disappearance from the urine
then became more rapid with about 10 µg/mL excreted at 48 hours. While
this study provided information on the elimination of 2-butanone from
plasma and urine of a human orally exposed, coexposure to the other
components of the cement could have influenced the elimination. 
No studies were located regarding the rate or extent of excretion of
2-butanone in animals following oral exposure. 
2.3.4.3 Dermal Exposure 
No studies were located regarding the rate or extent of excretion of
2-butanone in humans or animals following dermal exposure. 
2.4 RELEVANCE TO PUBLIC HEALTH
 The only known effects of 2-butanone in humans are related to its
irritating properties on the respiratory and dermal/ocular systems.
Effects 
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observed in animals include death, irritation of respiratory tissue, eyes,
and skin, liver congestion, kidney congestion, cornea1 opacity, narcosis
and incoordination, and fetotoxicity. 
No acute-, intermediate-, or chronic-duration inhalation MRLs were
derived for 2-butanone. In the case of acute-duration inhalation exposure,
target organs have not been sufficiently identified. Intermediate-duration
inhalation studies likewise failed to identify target organs, and nose and
throat irritation occurred in humans exposed for 5 minutes to exposure
levels that were much lower than NOAEL values in animals in intermediate-
duration studies. No studies were located regarding toxic effects in
humans or animals after chronic inhalation exposure, precluding the
derivation of a chronic inhalation MRL. No acute, intermediate-, or
chronic-duration oral KRLs were derived for 2-butanone. In the case of 
acute-duration oral exposure, target organs have not been sufficiently
identified. The paucity of information on toxic effects after
intermediate- and chronic-duration oral exposure likewise
precludes the derivation of MRLs for these durations. Acute-duration,
intermediate-duration, and chronic-duration dermal MRLs were not derived
for 2-butanone due to the lack of appropriate methodology for the
development of dermal MRLs. 
Death. No studies were located regarding death of humans after
inhalation, oral, or dermal exposure to 2-butanone. Death of rats and mice
occurred within a few hours during acute inhalation exposure to very high
concentrations (greater than or equal to 90,000 ppm) (Klimisch 1988;
LaBelle and Brieger 1955). The inhalation 4-hour LC50 in rats was 11,700
ppm (LaBelle and Brieger 1955). In the intermediate-duration studies, no
rats died after exposure to 5,000 ppm or less for 6 hours/day, 5 days/week
for 90 days(Cavender et al. 1983), but all rats exposed to 6,000 ppm, 8
hours/day, 7 days/week died from bronchopneumonia (Altenkirch et al.
1978a, 1978b). The bronchopneumonia may have been caused by the 2-butanone
exposure because the results were reproducible and did not occur in rats
exposed to n-hexane or the combination of 2-butanone and n-hexane
(Altenkirch et al. 1978a, 1978b). The concentration of 2-butanone that
would cause death in humans after inhalation is not known. It does not 
seem likely that humans would be exposed to the high concentrations that
are fatal to animals except in an occupational accident. 2-Butanone has a
half-life in air of only 14 hours; therefore, in the vicinity of toxic
waste sites, ambient concentrations would be expected to be low. 
Information regarding death from oral and dermal exposure is limited
to LD50 determinations. Oral LD50 values have been reported to be
approximately 2,740 mg/kg in immature, young adult, and older Sprague-
Dawley rats (Kimura et al. 1971), 5,542 mg/kg in Wistar rats (Smyth et al.
1962), and 4,044 mg/kg in mice (Tanii et al. 1986). The dermal LD50 in 
rabbits is greater than 10 mL/kg (Smyth et al. 1962). Oral exposure of
humans to 2-butanone might occur through drinking water if this chemical
seeped from a waste site, for example, into the groundwater. 2-Butanone is
highiy water soluble and is 
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expected to have a high soil mobility. Exposure through drinking water
is,therefore, possible, but fatal concentrations are unlikely
Dermalexposure of humans is unlikely to result in death. 
Systemic Effects. There are few known systemic effects of 2-butanone
exposure in humans. Three men exposed to 2-butanone vapors while removing
paint from an airplane hangar developed mild respiratory symptoms;
however, the nature and extent of these symptoms were not described (Berg
1971). One of the men suffered a loss of vision secondary to retrobulbar
neuritis, but this was reversed within 36 hours. Furthermore, exposure to
methanol could not be ruled out. Nelson et al. (1943) reported that 100
ppm 2-butanone caused slight nose and throat irritation, and that some
subjects complained of mild eye irritation at 200 ppm. Subjects could not
tolerate 350 ppm 2-butanone. For this study, it was estimated that 200 ppm
would be the maximum concentration of 2-butanone tolerable for an 8-hour 
exposure period. No adverse effects were reported in several studies
exposing volunteers to 200 ppm 2-butanone for 4 hours (Dick et al. 1984,
1988, 1989; Liira et al. 1988a, 1988b). In contrast, sporting goods
manufacturing plant workers exposed to 250 ppm or less complained of skin,
eye, nose, and throat irritation, and central nervous system symptoms
(headache, dizziness, fatigue)(Lee and Murphy 1982). One worker in this
group complained of "acting differently," but the change in behavior was
not described. These exposures were in enclosed areas with poor
ventilation. Exposure at the sporting goods factory was not to 2-butanone
exclusively; other solvent vapors were also present. Therefore, the
central nervous system symptoms described may not have been due solely to
2-butanone. 
Respiratory Effects. The respiratory effects observed in humans are
discussed above. Upper respiratory tract irritation was reported in rats
exposed for a few hours to 10,000 ppm 2-butanone (Altenkirch et al.
1978a). After the concentration was lowered to 6,000 ppm, all the rats
died suddenly at 7 weeks. Bronchopneumonia was confirmed pathologically as
the cause of death. In contrast, no respiratory tract irritation or
infection was observed in rats,exposed to 5,000 ppm 2-butanone for 90 days
(Cavender et al. 1983). Patty et al. (1935) reported that acute
inhalation exposure of guinea pigs to 10,000 ppm or more of 2-butanone
produced gasping respiration, emphysematous lungs, ocular irritation, and
lacrimation. Exposure to 100,000 ppm for 30 minutes or more caused cornea1
opacity, a condition which gradually improved in guinea pigs that lived 8
days after exposure. Since 2-butanone exposure is not tolerable to humans
at concentrations of 350 ppm (Nelson et al. 1943), it is highly unlikely
that inhalation exposure could result in respiratory, dermal, or ocular
effects more serious than minor irritation. Dermal exposure of humans,
rabbits, and guinea pigs has produced irritation to the skin (Anderson et
al. 1986; Hazleton Laboratories 1963a; Wahlberg 1984). Intraocular 
exposure of rabbits has resulted in cornea1 damage (Hazleton Laboratories
1963b; Kennah et al. 1989). Dermal and eye contact with liquid 2-butanone
is possible in occupational settings and at hazardous waste sites. 
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Hepatic Effects. No studies were located regarding hepatic effects
in humans after inhalation, oral, or dermal exposure to 2-butanone. Animal
data indicate that hepatic effects after high-level exposure to 2-butanone
would be minimal in humans. Liver congestion was found in guinea pigs
exposed acutely by inhalation to 10,000 ppm or more (Patty et al. 1935).
Serum concentrations of hepatic enzymes were not changed in rats after 2­
butanone exposures of 300-5,000 ppm for l-12 weeks (Cavender et al. 1983;
Li et al. 1986; Schwetz et al. 1974). No lesions that could be linked to
2-butanone exposure were found following histological examination,
although a slight increase in absolute and relative liver weight was noted
(Cavender et al. 1983). After exposure of rats to 800 ppm 2-butanone for 5
weeks, no changes were observed in the content of hepatic cytochrome P-450
or in the cytochrome P-450 isozyme profile (Toftgard et al. 1981).
2-Butanone, however, altered the metabolism of androstenedione by
increasing the formation of two metabolites and decreasing the formation
of two other metabolites. Furthermore, liver weight was increased in the
2-butanone-exposed rats (Toftgard et al. 1981). While no induction of
microsomal enzymes was found in rats exposed to 2-butanone by inhalation,
several studies have shown that E-butanone has the ability to induce
microsomal liver enzymes in rats after acute oral exposure (Brady et al.
1989; Raunio et al. 1990; Robertson et al. 1989; Traiger et al. 1989).
These studies also suggested that 2-butanone potentiates the toxicity of
other chemicals, such as, carbon tetrachloride, n-hexane, m-xylene, and
chloroform, by increasing their metabolism to toxic metabolites. While
enzyme induction by itself represents a normal physiological response to a
xenobiotic rather than an adverse effect, the enzyme induction by 2­
butanone can be viewed as an adverse effect if coexposure to other
chemicals for which 2-butanone potentiates toxicity by this mechanism
occurs. Therefore, humans working or living near hazardous waste sites
where these chemicals are present along with 2-butanone may be at greater
risk of adverse hepatic effects. 
Renal Effects. Renal effects of 2-butanone exposure in humans would
probably be minimal based on animal data. Kidney congestion was found in
guinea pigs exposed acutely by inhalation to 10,000 ppm or more (Patty et
al. 1935). Cavender et al. (1983) assessed kidney function with
measurements of blood urea nitrogen, urine volume, urine specific gravity,
and pH after a go-day exposure to 5,000 ppm 2-butanone. All values were
within normal ranges, and no histopathological lesions attributable to 2­
butanone exposure were found. Oral exposure of rats to 1,080 mg 2­
butanone/kg caused mild renal tubule necrosis but had no effect on renal
organic ion transport or plasma creatinine; therefore, in spite of mild
necrosis, normal kidney functions were not impaired. Exposure of humans to
2-butanone at hazardous waste sites is, therefore, not likely to result in
severe kidney effects. 
Neurological Effects. The main neurological complaints of humans
exposed occupationally to 2-butanone are headaches, dizziness, nausea, and
fatigue (Lee and Frederick 1981; Lee and Parkinson 1982). However, these
symptoms were not reported in several inhalation studies in which humans
were exposed to 200 ppm of 2-butanone for 4 hours (Dick et al. 1984, 1988,
1989; Liira 
35 
2. HEALTH EFFECTS 
et al. 1988a, 1988b). In the occupational exposures cited, 2-butanone was
combined with several other solvents; therefore, a neurological effect
exclusive to 2-butanone cannot be inferred. Dick et al. (1984, 1988, 1989)
found that exposure to 2-butanone had no effect on any neurobehavioral
measurement. Nevertheless, early signs of narcosis and incoordination
based on a battery of neurobehavioral tests were described in juvenile
baboons after continuous exposure to 100 ppm 2-butanone for 7 days (Geller
et al. 1979). It is also possible that the baboons were distracted during
testing by the irritant effects of 2-butanone on the respiratory tract and
were not, as the investigators concluded, in a state of narcosis. 
Narcosis and incoordination were also observed in guinea pigs
exposed to 10,000 ppm or more 2-butanone in air for a few hours (Patty et
al. 1935). 2-Butanone was not neurotoxic at lower concentrations in longer
duration studies in animals. Rats continuously exposed to 1,125 ppm for 5
months showed no signs of peripheral neuropathy on histological
examination (Saida et al. 1976). Altenkirch et al. (1978a) observed no
clinical signs of neuropathy in rats exposed for 7 weeks to 6,000 ppm. No
neurological effects were observed in rats exposed by inhalation to\ 5,000
ppm for 90.days (Cavender et al. 1983). Alterations in nerve conduction
velocity were seen in rats exposed by inhalation for 4 weeks to 200 ppm 2­
butanone (Takeuchi et al. 1983). The toxicological significance of this
observation is questionable because normal nerve conduction velocities
were observed at all time points beyond 4 weeks. No neurological effects
were observed in rats after oral exposure to 1,725 mg/kg for 90 days
(Ralston et al. 1985). Therefore, exposure of humans to 2-butanone alone
in the workplace or at hazardous waste sites is not likely to result in
serious neurological effects. 
Although exposure to 2-butanone appears relatively innocuous, this
ketone is very hazardous in combination with other solvents. 2-Butanone
markedly potentiates the neurotoxicity of ethanol, n-hexane, methyl-n­
butyl ketone, and ethyl-n-butyl ketone (Altenkirch et al. 1977; Cunningham
et al. 1989; King et al. 1985; Ralston et al. 1985; Robertson et al. 1989;
Vallat et al. 1981). Glue formulations containing both 2-butanone and n-
hexane caused "glue sniffers' neuropathy" (Altenkirch et al. 1977; King et
al. 1985; Vallat et al. 1981). This neuropathy is characterized by motor
nerve dysfunction, paresis, paralysis, muscular atrophy, and neural tissue
morphology changes including paranodal axon swelling, neurofilamentous
hyperplasia, and demyelination (see Section 2.6). Therefore, humans
working or living near hazardous waste sites where methyl-n-butyl ketone,
ethyl-n-butyl ketone, or n-hexane is present or who frequently use alcohol
may be at greater risk for neurological effects if 2-butanone is also
present. 
Developmental Effects. No studies were located regarding
developmental effects in humans following inhalation, oral, or dermal
exposure to 2-butanone. Inhalation exposure of rats and mice to 3,000 ppm
during gestation resulted in fetotoxic effects, such as reduced fetal
weight, skeletal variations, and delayed ossification (Deacon et al. 1981;
Mast et al. 
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1989; Schwetz et al. 1974). It is not known whether exposure of humans to
2-butanone by any route would result in fetotoxic effects, but the
presence of these effects in two animal species strongly suggests that
such effects might occur in humans. 
Reproductive Effects. No studies were located regarding reproductive
effects in humans following inhalation, oral, or dermal exposure to
2-butanone. The only study regarding reproductive effects in animals was a
go-day inhalation study in rats exposed to 5,000 ppm or less of 2-butanone
(Cavender and Casey 1981; Cavender et al. 1983). Histological examination
of male and female reproductive organs revealed no effects, but
reproductive function was not tested. 
Genotoxic Effects. In vivo and in vitro studies regarding the
genotoxicity of 2-butanone are summarized in Table 2-4. No induction of
micronuclei was found in the erythrocytes of mice (O'Donoghue et al. 1988)
or hamsters (Basler 1986) after intraperitoneal injection with 2-butanone.
&I vitro studies sponsored by the Chemical Manufacturers' Association
showed that 2-butanone was not mutagenic in the Salmonella/mammalian­
microsome preincubation mutagenicity assay (Ames test) or the L5178Y TK
+/- mouse lymphoma mutagenesis assay with or without activation
(O'Donoghue et al. 1988). 2-Butanone did not induce unscheduled DNA
synthesis in rat primary hepatocytes, and it did not transform BALB/3T3
cells. 2-Butanone did not increase the reverse mutation frequency in
Escherichia coli or Salmonella tvohimurium, with or without activation,
and did not increase the frequency of chromatid gaps, chromatid breaks, or
total chromatid aberrations in rat liver cells (Thorpe 1982). 2-Butanone
did not cause gene mutations in Saccharomvces cerevisiae (Thorpe 1982),
but cause mitotic chromosome loss (Whittaker et al. 1990; Zimmermann et
al. 1989) and aneuploidy in S. cerevisiae (Mayer and Goin 1987) at high
concentrations. The positive induction of chromosome loss in the yeast
cells was enhanced by coexposure to 2-butanone, ethyl acetate, and
propionitrile (Zimmermann et al. 1989). The positive induction of
aneuploidy was enhanced by coexposure to 2-butanone and nocodazole (Mayer
and Goin 1987). It appears, therefore, that 2-butanone alone is not
genotoxic to humans. 
Cancer. Two retrospective epidemiological studies of industrial
workers chronically exposed to 2-butanone in dewaxing plants reported that
deaths due to cancer were less than expected (Alderson and Rattan 1980;
Wen et al. 1985).
 No other studies were located regarding cancer in humans or animals
following inhalation exposure to 2-butanone. 
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2.5 BIOMARRERS OF EXPOSURE AND EFFECT 
Biomarkers are broadly defined as indicators signaling events in
biologic systems or samples. They have been classified as markers of
exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989). 
A biomarker of exposure is a xenobiotic substance or its
metabolite(s) or the product of an interaction between a xenobiotic agent
and some target molecule(s) or cell(s) that is measured within a
compartment of an organism(NAS/NRC 1989). The preferred biomarkers of
exposure are generally the substance itself or substance-specific
metabolites in readily obtainable body fluid(s) or excreta. However,
several factors can confound the use and interpretation of biomarkers of
exposure. The body burden of a substance may be the result of exposures
from more than one source. The substance being measured may be a
metabolite of another xenobiotic substance (e.g., high urinary levels of
phenol can result from exposure to several different aromatic compounds).
Depending on the properties of the substance (e.g., biologic half-life)
and environmental conditions (e.g., duration and route of exposure), the
substance and all of its metabolites may have left the body by the time
biologic samples can be taken. It may be difficult to identify individuals
exposed to hazardous substances that are commonly found in body tissues
and fluids (e.g., essential mineral nutrients such as copper, zinc,
and selenium). Biomarkers of exposure to 2-butanone are discussed in
Section 2.5.1. 
Biomarkers of effect are defined as any measurable biochemical,
physiologic, or other alteration within an organism that, depending on
magnitude, can be recognized as an established or potential health
impairment or disease (NAS/NRC 1989). This definition encompasses
biochemical or cellular signals of tissue dysfunction (e.g., increased
liver enzyme activity or pathologic changes in female genital epithelial
cells), as well as physiologic signs of dysfunction such as increased
blood pressure or decreased lung capacity. Note that these markers are
often not substance specific. They also may not be directly adverse, but
can indicate potential health impairment (e.g., DNA adducts). Biomarkers
of effects caused by 2-butanone are discussed in Section 2.5.2.
 A biomarker of susceptibility is an indicator of an inherent or
acquired limitation of an organism's ability to respond to the challenge
of exposure to a specific xenobiotic substance. It can be an intrinsic
genetic or other characteristic or a preexisting disease that results in
an increase in absorbed dose, biologically effective dose, or target
tissue response. If biomarkers of susceptibility exist, they are discussed
in Section 2.7, "POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE." 
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2.5.1 Biomarkers Used to Identify and/or Quantify Exposure to 2-Butanone. 
Inhalation exposure to 2-butanone correlates well with blood,
breath, and urinary concentrations of unchanged 2-butanone (Brown et al.
1986; Brugnone et al. 1983; Ghittori et al. 1987; Miyasaka et al. 1982).
Personal dosimetry was used to measure exposure to 2-butanone among 62
printing plant workers(Miyasaka et al. 1982) and 659 workers in plastic
boat, chemical, plastic button, paint, and shoe factories (Ghittori et al.
1987). The correlation between exposure levels and urinary concentration
of unchanged 2-butanone was strong in each study (r=O.774 and r=0.91,
respectively). Miyasaka et al. 1982) concluded, however, that estimating
exposure from urinary levels was reliable on a group basis but not an
individual basis. Blood and breath levels of 2-butanone were significantly
correlated (r=0.78, p<O.OOl) in volunteers exposed to 200 ppm 2-butanone
for 4 hours (Brown et al. 1986). A significant correlation between
workroom and urinary 2-butanone concentrations was observed in shoe
factory workers (r=0.6877, p<O.OOl) (Brugnone et al. 1983). In the same
study, a more significant correlation was observed between workroom
concentrations and a 2-butanone urinary metabolite, 3-hydroxy-2-butanone
(r=0.8179, p<O.OOl). Another 2-butanone metabolite, 2,3-butanediol, has
also been identified in the urine of humans (Liira et al. 1988a, 1988b).
No studies were located regarding the correlation between exposure to 2­
butanone and urinary levels of the metabolite, 2,3-butanediol. A third
metabolite, 2-butanol, was identified in guinea pig-blood; however, no
attempt was made to correlate 2-butanol blood levels with exposure to
2-butanone (DiVincenzo et al. 1976). Metabolism of alcohols, hydrocarbons,
and other ketones may also yield 2-butanone, 3-hydroxy-2-butanone, and
2,3-butanediol (Dietz and Traiger 1979; Tsukamoto et al. 1985a); therefore,
these compounds may confound assessment of exposure to 2-butanone. 
Measurements of tissue, blood, and excreta levels may not be an
accurate indication of past exposure to 2-butanone. Accumulation in target
tissues does not occur because tissue/blood solubility ratios are all near
unity; therefore, 2-butanone will not concentrate in specific tissues
(Perbellini et al. 1984). The serum half-life of 2-butanone in humans is
very short;estimates range from 49 to 96 minutes (Liira et al. 1988a;
Lowry 1987). Furthermore, 2-butanone was not detectable in blood or
breath measurements reported the morning after a 4-hour exposure to 200
ppm (Brown et al. 1987). 
No quantifiable effects that could be used as biomarkers of exposure
to 2-butanone were identified. 
2.5.2 Biomarkers Used to Characterize Effects Caused by 2-Butanone 
2-Butanone induces hepatic microsomal enzymes in rats after oral
exposure(Brady et al. 1989; Raunio et al. 1990, Robertson et al. 1989;
Traiger et al. 1989), but this enzyme induction has not been associated
with more severe liver effects. No other subtle biochemical effects of 2 
butanone have been 
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identified that would be useful as biomarkers to characterize effects of 
2-butanone. 
2.6 INTERACTIONS WITH OTHER CHEMICALS 
The neurological and hepatic effects of 2-butanone alone are minimal.
For certain applications, 2-butanone is combined with other chemicals that
have serious neurotoxic or hepatotoxic effects. Clinical reports and animal
studies have clearly shown that 2-butanone potentiates both the neurotoxicity
of ethanol, n-hexane, and methyl-n-butyl ketone and the hepatotoxicity of
carbon tetrachloride and chloroform. 
Altenkirch et al. (1977) investigated a large outbreak of toxic
polyneuropathies in a group of West Berlin "glue sniffers." The development
of neuropathies (muscular atrophy, paresthesia, paresis, quadriplegia)
coincided with a change in the composition of a glue that was popular for
sniffing. Until the fall of 1975, the major constituents of the glue were n-
hexane, toluene, ethyl acetate, and benzene. At this time, 2-butanone was
added to the mixture and the sudden appearance of the toxic neuropathies
began. 
A 39-year-old woman who had worked for several years gluing shoes
developed polyneuropathy after a few weeks of work in a poorly ventilated shop
(Vallat et al. 1981). The glue she was using contained 20% 2-butanone and 8%
n-hexane. 
"Glue sniffing neuropathy" was also described in a clinical case report
of three men who had similar symptoms (King et al. 1985). All had been
sniffing the same brand of glue containing light, volatile hydrocarbons(Ce-
C,), toluene, and 2-butanone. P-Butanone had recently been added to the glue
formulation, and the authors suggested that this may have increased the
neurotoxicity. A change in the formulation of a solvent compound also
precipitated a sudden outbreak of peripheral neuropathy in a coated fabrics
plant (Allen et al. 1975; Billmaier et al. 1974). Methyl-n-butyl ketone
introduced into a solvent used at the plant was implicated as the causative
agent; however, the solvent also contained high concentrations of 2-butanone.
Combined exposure to 2-butanone and methyl-n-butyl ketone has not been studied
meepidemiologically in humans; therefore, whether P-butanone potentiates methyl-
n-butyl ketone neurotoxicity in humans is not known (Katz 1985). 
The potentiation of the neurotoxicity of n-hexane and methyl-n-butyl ketone
by 2-butanone is well-documented in animals (Altenkirch et al. 1978a, 1978b,
1982a, 1982b; Saida et al. 1976; Takeuchi et al. 1983). Altenkirch et al.
(1978a) exposed rats to either 10,000 ppm n-hexane or a combination of 1,000
ppm 2-butanone and 9,000 ppm n-hexane. A summary of three experiments under
these conditions showed that rats exposed to the combination of n-hexane and
2-butanone developed paresis more rapidly and in greater numbers than rats
exposed to n-hexane only. In the same study, rats exposed to 6,000 ppm 
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2-butanone only showed no signs of neurotoxicity up to 7 weeks, when all
the rats in this group died suddenly of bronchopneumonia. These results
were confirmed in a second study; mixtures of 500 ppm n-hexane and 2­
butanone (4:l or 3:2) or 700 ppm (5:2) caused clinical signs of neuropathy
l-5 weeks earlier than 500 ppm n-hexane alone (Altenkirch et al. 1982a).
Histological examination revealed morphological changes in the rats
similar to those found in youths suffering from glue sniffing neuropathy,
including paranodal axon swelling, accumulation of neurofilaments in the
cytoplasm, and demyelination. Takeuchi et al. (1983) observed a
significant decrease in motor nerve conduction velocity in rats exposed to
300 ppm n-hexane:2-butanone (1:2). In this study, motor nerve conduction
velocity increased in rats exposed to 200 ppm 2-butanone alone and did not
change in rats exposed to 100 ppm n-hexane alone. Male Wistar rats exposed
to n-hexane or a combination of n-hexane and 2-butanone developed
ultrastructural changes in the intrapulmonary nerves characteristic of
hexacarbon neurotoxicity (Schmidt et al. 1984). Concomitant exposure to n-
hexane and 2-butanone decreased the onset of observable neuropathological
changes. 
Saida et al. (1976) reported a marked potentiation of peripheral
neurotoxicity when rats were exposed to methyl-n-butyl ketone:2-butanone
(225:1,125 ppm). Rats exposed to methyl-n-butyl ketone only developed
paralysis by 66 days. The combination caused paralysis in 25 days, while 
2-butanone alone had no effect up to 5 months. Histological examination of
neurons revealed morphological changes similar to those reported by
Altenkirch et al. (1982a), which included paranodal axon swelling,
accumulation of neurofilaments, and demyelination. Subcutaneous injection
of methyl-n-butyl ketone with or without 2-butanone increased distal motor
latency and decreased motor fiber conduction velocity in male Donryu
strain rats (Misumi and Nagano 1985). The combination of the two ketones
enhanced these effects. 
In vitro studies support the hypothesis that 2-butanone potentiates
n-hexane and methyl-n-butyl ketone neurotoxicity. Veronesi et al.
(1984)observed that, in tissues cultured from fetal mouse spinal cord,
dorsal root ganglia, and muscle, the combination of 2-butanone and n-
hexane produced giant axonal swellings more rapidly than cultures treated
with n-hexane alone. Furthermore, cultures exposed to nontoxic
concentrations of n-hexane also developed giant axonal swellings when 2­
butanone was administered concomitantly.
 Biotransformation of both n-hexane and methyl-n-butyl ketone can
produce 2,5-hexanedione (Couri et al. 1978; DiVincenzo et al. 1976;
Robertson et al. 1989). This compound is the most potent neurotoxic
metabolite of n-hexane and methyl-n-butyl ketone known (Katz 1985).
2-Butanone may potentiate n-hexane and methyl-n-butyl ketone neurotoxicity
by enhancing their metabolic conversion to 2,5-hexanedione. Combined
administration of methyl-n-butyl ketone and 2-butanone produced more
2,5-hexanedione than administration of methyl-n-butyl ketone alone (Couri
et al. 1978). The concentrations of the n-hexane metabolites
2,5-hexanedione and 2,5-dimethylfuran were significantly 
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higher in the blood and sciatic nerve of rats pretreated by gavage with
2-butanone followed by inhalation exposure to n-hexane compared with rats
exposed to n-hexane alone (Robertson et al. 1989). In addition,
concomitant oral administration of 2-butanone and 2,5-hexanedione in rats
reduced blood 2,5-hexanedione clearance (Ralston et al. 1985). 
Ethyl-n-butyl ketone is a weak neurotoxin (O'Donoghue et al. 1984).
Oral administration in rats for several weeks caused the paranodal axon
swelling and neurofilamentous hyperplasia characteristic of n-hexane and
methyl-n-butyl ketone neurotoxicity. Biotransformation of ethyl-n-butyl
ketone produced two neurotoxic metabolites, 2,5-hexanedione and 2,5­
heptanedione. 2,5-Heptanedione can be further metabolized to 2,5
hexanedione. Concomitant inhalation exposure to 700 ppm ethyl-n-butyl
ketone and 700 ppm 2-butanone for 4 consecutive days caused a 2.6-fold
increase in the serum concentration of 2,5-heptanedione. Oral
administration of 2-butanone potentiated the development of clinical and
histological signs of ethyl-n-butyl neurotoxicity.
 2-Butanone has also been found to potentiate the neurotoxicity of
ethanol (Cunningham et al, 1989). Mice pretreated intraperitoneally with
2-butanone followed by intraperitoneal injection of ethanol 30 minutes
later showed prolonged loss of righting reflex induced by ethanol. 2­
Butanone also decreased the rate of ethanol elimination in mice in vivo 
and inhibited the in vitro activity of alcohol dehydrogenase, the main
mechanism for ethanol elimination. These results suggest that 2-butanone
potentiated the neurotoxicity of-ethanol by inhibiting its metabolism by
alcohol dehydrogenase. 
2-Butanone is not a universal potentiator of hydrocarbon- and
aliphatic ketone-induced neuropathies (O'Donoghue et al. 1982).
Concomitant oral administration of 2-butanone and 5-nonanone did not 
potentiate the neurotoxicity of 5-nonanone. 
2-Butanone alone is minimally neurotoxic (Altenkirch et al. 1978a;
Saida et al. 1976). This compound, however, is frequently mixed with n-
hexane and methyl-n-butyl ketone for various commercial and industrial
applications. The previous discussion emphasizes the public health hazard
of mixed solvent exposure to 2-butanone. Exposure to a mixed solvent is
more likely to occur in an occupational setting or at a hazardous waste
site, than exposure to 2-butanone alone. 
2-Butanone alone is not highly hepatotoxic (see the discussion of
Hepatic Effects in Section 2.2.1.2) but has a well-documented role in
potentiating haloalkane-induced hepatotoxicity (Brown and Hewitt 1984;
Dietz and Traiger 1979; Hewitt et al. 1983, 1986, 1987; Tanii et al.
1986). Intraperitoneal injection of chloroform (0.5 mL/kg) caused a nine­
fold increase in rat SGPT activity (Brown and Hewitt 1984). In contrast,
chloroform injection caused a 195-fold increase in rat SGPT activity if
administered 18 hours after oral administration of 2-butanone. Similarly,
intraperitoneal injection of 
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chloroform increased rat plasma ornithine carbamyl transferase activity
215-fold if given 18 hours after oral administration of 2-butanone (Hewitt
et al. 1983). In addition to the doses administered, the length of time
between administration of 2-butanone and the chloroform injection
determined the severity of hepatotoxicity (Hewittet al. 1987).
Measurements of SGPT and plasma ornithine carbamyl transferase revealed
that 2-butanone is most efficacious for potentiation of chloroform-induced
hepatotoxicity if administered 18 hours before chloroform. 
2-Butanone also potentiates carbon tetrachloride-induced
hepatotoxicity (Dietz and Traiger 1979; Traiger et al, 1989). Measurement
of SGPT activity and hepatic triglyceride content showed that
administration of 2-butanone 16 hours before intraperitoneal injection of
carbon tetrachloride significantly enhanced liver damage. The mechanism of
P-butanone potentiation of chloroform and carbon tetrachloride
hepatotoxicity may be related to biotransformation of the ketone to its
metabolite, 2,3-butanediol. Carbon tetrachloride increased rat SGPT 164­
fold when injected 16 hours after oral administration of 2,3-butanediol.
Replacement of 2,3-butanediol with 2-butanone increased the transaminase
66-fold. Hepatic triglyceride content was potentiated to a similar degree
by both 2-butanone and 2,3-butanediol. However, the maximal potentiation
of carbon tetrachloride-induced hepatic injury by pretreatment with 2­
butanone coincided with increased microsomal enzyme activity within the
same time frame following exposure to 2-butanone alone (Traiger et al.
1989). This strongly suggests that 2-butanone potentiates the
hepatotoxicity of carbon tetrachloride by enhancing its metabolism to
toxic intermediates. The mechanism of 2-butanone potentiation of
chloroform-induced hepatotoxicity apparently does not involve
biotransformation of chloroform to a reactive intermediate, an alteration
of the cytochrome P-450 system, or depletion of liver glutathione (Hewitt
et al. 1987). It is possible that 2,3-butanediol also contributes to the
toxicity of chloroform. 
Pretreatment of ddY mice with carbon tetrachloride 24 hours before 
oral administration of 2-butanone reduced the 2-butanone LD,, about 20%
(Tanii et al. 1986). The mechanism of this effect was not investigated. 
Exposure of pregnant rats continuously to n-hexane alone (l,OOO­
1,500 ppm) or n-hexane and 2-butanone (1,200 ppm n-hexane, 300 ppm 2­
butanone) throughout gestation and/or during the postnatal period resulted
in reduced birth weight of pups, and weight gain reduction persisted
during the postnatal exposure period (Stoltenburg-Didinger et al. 1990).
The effect was more pronounced with the mixture of solvents. In addition,
hindlimb weakness in one dam during the gestational exposure period
progressing to quadriplegia in all dams during the postpartum exposure
period was for the solvent mixture, while only hindlimb weakness was




 Coexposure of S. cerevisiae to 2-butanone, ethyl acetate, and propionitrile
enhanced the induction of chromosome loss caused by 2-butanone (Zimmermann et
al. 1989). Coexposure of S. cerevisiae to 2-butanone and nocodazole enhanced the
induction of aneuploidy caused by 2-butanone alone (Mayer and Goin 1987). 
2.7 POPULATIONS THAT ABE UNUSUALLY SUSCEPTIBIE 
No studies were located that identified populations that are unusually
susceptible to adverse health effects after exposure to 2-butanone. The very
young and the very old are typically more susceptible to chemical, toxicity than
are older children, adolescents, and healthy adults. Individuals that are
alcoholics and those with existing liver disease would be expected to metabolize
2-butanone differently than the general population. Persons with existing
neuropathies may also be more susceptible. Exposure to both 2-butanone and n-
hexane or methyl-n-butyl ketone is possible in occupational settings and at
hazardous waste sites; thus, neurological effects of n-hexane and methyl-n-butyl
ketone may be greater with coexposure to 2-butanone. Likewise, occupational
exposure or exposure at hazardous waste sites to a combination of 2-butanone and
the haloalkanes, carbon tetrachloride, or chloroform, presents a greater risk
for liver damage. 
2.8 MITIGATION OF EFFECTS 
This section will describe clinical practice and research concerning
methods for reducing toxic effects of exposure to 2-butanone. This section is
intended to inform the public of existing clinical practice and the status of
research concerning such methods. However, because some of the treatments
discussed may be experimental and unproven, this section should not be used as a
guide for treatment of exposures to 2-butanone. When specific exposures have
occurred, poison control centers and medical toxicologists should be consulted
for medical advice. 
2-Butanone has a low order of systemic toxicity. The main effects in
humans are irritation of respiratory tissues and eyes and nonspecific
neurological effects, such as headache, dizziness, nausea, and fatigue. Such
effects are characteristic of solvent exposure and are mitigated primarily by
removing affected individuals from exposure conditions and decontaminating
exposed areas (Bronstein and Currance 1988; Stutz and Janusz 1988). For example,
contaminated clothing is removed and skin washed. If the eyes were exposed, they
are flushed with water. For ingestion of 2-butanone, there is controversy as to
whether or not to administer emetics. The controversy centers around the risk of
aspiration of vomitus into the lungs during emesis. Administration of activated
charcoal has been suggested to reduce gastrointestinal absorption. Please refer
to Bronstein and Currance (1988) and Stutz and Janusz (1988) for more complete
information.
 Although 2-butanone alone is not highly neurotoxic or hepatotoxic, it
potentiates the neurotoxicity of n-hexane and methyl-n-butyl ketone, and the
hepatotoxicity of chloroform and carbon tetrachloride (see Section 2.6).
Exposure to 2-butanone with other solvents is more likely than exposure to 2­
butanone alone in occupational and environmental settings. Since both n-hexane
and methyl-n-butyl ketone can be 
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metabolized to 2,5-hexanedione (Couri et al. 1978; DiVincenzo et al 1976),
a potent neurotoxic agent (Katz 1985), 2-butanone may potentiate the
neurotoxicity of the other chemicals by enhancing the biotransformation of
n-hexane and methyl-n-butyl ketone to 2,5-hexanedione by inducing
microsomal enzymes. The potentiation of the hepatotoxicity of carbon
tetrachloride and chloroform by 2-butanone may be related to the
biotransformation of 2-butanone to 2,3-butanediol, a metabolite that
potentiates the hepatotoxicity of carbon tetrachloride to a greater extent
than does 2-butanone (Dietz and Traiger 1979). Alternatively, the
induction of microsomal enzymes by 2-butanone may enhance the
biotransformation of chloroform and carbon tetrachloride to toxic 
intermediates (Brady et al. 1989; Traiger et al. 1989). If carbon
tetrachloride or chloroform shift metabolic pathways of 2-butanone in
favor of greater formation of 2,3-butanediol, administration of an agent
that blocks this shift could mitigate the potentiation. 2-Butanone is
reduced to 2-butanol and oxidized to 3-hydroxy-2-butanone, which is
further reduced to 2,3-butanediol(DiVincenzo et al. 1976). However, the
enzyme systems involved in the biotransformation of 2-butanone have not
been characterized. Similarly, if 2-butanone enhances the metabolism of
chloroform and carbon tetrachloride by inducing microsomal enzymes, agents
that block this induction could mitigate this potentiation. 
2.9 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA as amended directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and
programs of the Public Health Service) to assess whether adequate
information on the health effects of 2-butanone is available. Where 
adequate information is not available, ATSDR, in conjunction with the
National Toxicology Program (NTP), is required to assure the initiation of
a program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of 2­
butanone. 
The following categories of possible data needs have been identified by a
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified data
needs will be evaluated and prioritized, and a substance-specific research
agenda will be proposed. 
2.9.1 Existing Information on Health Effects of 2-Butanone 
The existing data on health effects of inhalation, oral, and dermal
exposure of humans and animals to 2-butanone are summarized in Figure 2-4. The
purpose of this figure is to illustrate the existing information concerning the
health effects of 2-butanone. Each dot in the figure indicates that one or more
studies provide information associated with that particular effect. The dot does
not imply anything about the quality of the study or studies. Gaps in this
figure should not be interpreted as "data needs" information.
 Studies regarding the adverse health effects of exposure to 2-butanone in humans
is limited (Figure 2-4). No reports exist regarding death in humans 
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following exposure to 2-butanone by any route. Existing information
regarding systemic effects of 2-butanone exposure have come primarily from
two clinical reports involving accidental poisoning: one by oral exposure
and one by inhalation (Berg 1971; Kopelman and Kalfayan 1983). A clinical
study reported contact urticaria triggered by dermal -exposure to 2
butanone in a 48-year-old male painter (Varigos and Nurse 1986).
Intermediate dermal exposure to 2-butanone had no effect on humans
(Wahlberg 1984). Acute inhalation studies in humans showed no adverse
neurological effects (Dick et al. 1984, 1988, 1989). However, 2-butanone
produced nose, throat, and eye irritation in humans (Nelson et al. 1943).
Epidemiological studies showed no clear relationship between occupational
exposure to 2-butanone and the development of neoplasms (Alderson and
Rattan 1980; Wen et al. 1985). 
Animal studies regarding death after acute and intermediate exposure
to 2-butanone by inhalation, oral, dermal, and other routes are available.
Several studies are also available that show that acute and intermediate 
inhalation exposures have minimal or no systemic effects. Minimal effects
were limited to small increases in organ weight (Cavender et al. 1983;
Toftgard et al. 1981). Inhalation, oral, and dermal studies showed that
2-butanone is minimally neurotoxic in most species. Guinea pigs exposed
acutely to high concentrations (10,000 ppm) developed incoordination and
narcosis (Patty et al 1935). Juvenile baboons exposed to 100 ppm 2
butanone also appeared to show early signs of incoordination and narcosis
in a complex discriminant neurobehavioral test (Geller et al. 1979).
Histological examination of reproductive organs of male and female rats
exposed by inhalation to 5,000 ppm revealed no effects (Cavender and Casey
1981; Cavender et al. 1983). Studies of acute oral exposure showed that 2­
butanone caused renal tubular necrosis (Brown and Hewitt 1984; Hewitt et
al. 1983) and induced hepatic microsomal enzymes (Brady et al. 1989;
Raunio et al. 1990, Robertson et al. 1989; Traiger et al. 1989). One
intermediate oral exposure showed that 2-butanone was not neurotoxic
(Ralston et al, 1985). Acute and intermediate dermal exposures to 2­
butanone were mildly irritating to the skin of rabbits, rats, and guinea
pigs (Hazleton Laboratories 1963a; Wahlberg 1984). No reports of systemic
toxicity are available for dermal exposure. Several studies demonstrating
that 2-butanone is moderately irritating to the eyes of rabbits are
available. 2-Butanone was fetotoxic, causing delayed development in
fetuses of rats (Deacon et al. 1981; Schwetz et al. 1974) and mice (Mast
et al. 1989) exposed by inhalation. 
Several studies are available regarding 2-butanone potentiation of
n-hexane and methyl-n-butyl ketone neurotoxicity and 2-butanone
potentiation of haloalkane hepatotoxicity. 
2.9.2 Data Needs 
Acute-Duration Exposure. Several studies are available that report the
results of acute duration exposure to 2-butanone by inhalation, oral, and
dermal routes in both humans and animals. In acute inhalation studies, an 
48 
2. HEALTH EFFECTS 
LC50 value in rats (LaBelle and Brieger 1955) and other exposures that
caused death in rats (Klemisch 1988; Smyth et al. 1962), mice (LaBelle and
Brieger 1955), and guinea pigs (Patty et al. 1935) were identified. The
target organs identified in guinea pigs after acute inhalation exposure to
high concentrations of 2-butanone are the respiratory system, liver,
kidney, eye, and central nervous system Patty et al. 1935. Slight
neurotoxicity was also seen in mice and baboons exposed to low
concentrations (DeCeaurriz et al. 1983; Geller et al. 1979). Narcosis and
incoordination were observed in guinea pigs exposed acutely to high
concentrations of 2-butanone (Patty et al. 1935). An acute-duration
inhalation MRL was not derived because target organs of rats and mice have
not been sufficiently investigated. Although target organs of acute
inhalation exposure of rats and mice have not been sufficiently
investigated, intermediate duration studies indicate that effects on the
liver, kidney, respiratory system, and nervous system of rats are minimal.
In acute oral studies, LD50 values for rats (Kimura et al. 1971; Smyth et
al. 1962) and mice (Tanii et al. 1986) were available, and the kidney
was identified as a target (Brown and Hewitt 1984). No acute oral MRL was
derived because target organs have not been sufficiently investigated.
Furthermore, inhalation studies indicate that 2-butanone is a
developmental toxicant, but developmental effects after oral exposure were
not studied. Acute dermal studies have shown that 2-butanone is a skin 
and eye irritant in rabbits (Hazleton Laboratories 1963a, 1963b) and
guinea pigs (Anderson et al. 1986; Wahlberg 1984), but the systemic
toxicity of acute dermal exposure has not been investigated. The available
pharmacokinetic data are not sufficient to predict whether target organs
would be similar by the various routes of exposure. Acute exposure of
humans near a toxic waste site to 2-butanone alone would probably not have
serious clinical consequences. 2-Butanone is detectable by humans at
concentrations far below its OSHA and NIOSH permissible levels because of
its odor. Further acute exposure studies with 2-butanone alone would
probably not be useful. In contrast, further acute exposure studies by
oral, inhalation, and dermal routes of 2-butanone combined with such
hepatotoxins as chloroform and carbon tetrachloride, or with such
neurotoxins as n-hexane and methyl-n-butyl ketone would yield valuable
information on the potentiation of the hepatotoxicity and neurotoxicity,
resperhively, of the other-chemicals by 2-butanone. These chemicals are
often found together in formulations used occupationally and they might be
stored together at toxic waste sites. Therefore, workers and populations
surrounding hazardous waste sites might be exposed to these substances for
acute durations. 
Intermediate-Duration Exposure. A comprehensive 90-day inhalation
study in rats showed that 2-butanone did not have adverse effects in the
respiratory, cardiovascular, gastrointestinal, musculoskeletal,
hematological, hepatic, renal, or dermal/ocular systems (Cavender and
Casey 1981; Cavender et al. 1983). The most serious effect was slightly
increased liver weight at the highest concentration tested, 5,000 ppm.
Occupational exposures to concentrations this high are unlikely since
humans find 350 ppm 2-butanone intolerable (Nelson et al. 1943). No signs
of neurotoxicity, either clinical 
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or histological, were observed in several studies of intermediate
exposures to high concentrations of 2-butanone up to 6,000 ppm (Altenkirch
et al. 1978a, 1978b; Cavender and Casey 1981; Cavender et al. 1983).
Therefore, most organs and tissues in humans probably would not be
adversely affected by intermediate 2-butanone exposures either
occupationally or near toxic waste sites. An intermediate duration
inhalation MRL was not derived because nose and throat irritation occurred 
in humans at acute inhalation exposure levels lower than the NOAEL values
for intermediate duration inhalation exposure in animals. No intermediate
oral or dermal studies investigated the systemic toxicity of 2-butanone by
these routes, and the available pharmacokinetic data are not. Sufficient 
to predict whether target organs would be similar by the various routes of
exposure. 2-Butanone has been detected in air, water, food, and soil (see
Section 5.4); therefore, exposures by the inhalation, oral, and dermal
routes are possible. From a public health perspective, exposure to solvent
mixtures is more likely than exposure to a single pure chemical.
Therefore, intermediate exposure studies of 2-butanone mixed with other
solvents (hexacarbons and haloalkanes), the toxicity of which is
potentiated by 2-butanone, would provide valuable information on
neurotoxicity and systemic toxicity. This information is important since
these chemicals are often found together in solvents used occupationally, 
and they might be stored together at hazardous waste sites where
surrounding populations could be exposed for intermediate durations. 
Chronic-Duration Exposure and Cancer. No studies were located 
regarding the health effects of chronic exposure to 2-butanone by any
route in humans or animals, but acute and intermediate duration inhalation
studies indicated that by itself, 2-butanone is minimally toxic.
Pharmacokinetic data are insufficient to predict the possible target
organs of chronic exposure by any route. Since 2-butanone has been
detected in air, water, food, and soil (see Section 5.4), exposures by the
inhalation, oral, and dermal routes are possible. 2-Butanone is often
found in formulations with other chemicals, such as chloroform, carbon
tetrachloride, n-hexane, and methyl-n-butyl ketone, the toxicities of
which -2-butanone potentiates. These chemicals may be stored together at
hazardous waste sites. Chronic inhalation, oral, and dermal studies in
which animals are administered these chemicals in combination with 2­
butanone may provide dose-response information for the potentiation of the
neurotoxicity and hepatotoxicity of these chemicals by 2-butanone. This
information is important because there are populations surrounding
hazardous waste sites that might by exposed to these chemicals for similar
durations. 
Although no cancer bioassays were available, preliminary
epidemiological studies suggest that occupational exposure to 2-butanone
does not increase the development of neoplasms. Furthermore, 2-butanone
was not genotoxic, either with or without metabolic activation, in several
microorganisms and cultured mammalian cells (O'Donoghue et al. 1988;
Thorpe 1982). Furthermore, no induction of micronuclei was found in the
erythrocytes of hamsters (Basler 1986) or mice (O'Donoghue et al. 1988)
after intraperitoneal injection with 
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2-butanone. On the basis of this information, 2-butanone does not appear
to be carcinogenic. 
Genotoxicity. No induction of micronuclei was found in the 
erythrocytes of hamsters (Basler 1986) or mice (O'Donoghue et al. 1988)
after intraperitoneal injection with 2-butanone. A comprehensive battery
of in vitro tests showed that 2-butanone was not mutagenic in two
prokaryotic organisms and two eukaryotic organisms, did not transform
mammalian cells in culture, and did not induce unscheduled DNA synthesis
in rat primary hepatocytes (O'Donoghue et al. 1988; Thorpe 1982). 2­
Butanone did not cause gene mutations in S. cerevisiae (Thorpe 1982), but
caused mitotic chromosome loss (Whittaker et al. 1990; Zimmermann et al.
1989) and aneuploidy in S. cerevisiae (Mayer and Goin 1987) at high
concentrations. The positive induction of chromosome loss in the yeast
cells was enhanced by coexposure to 2-butanone, ethyl acetate, and
propionitrile (Zimmermann et al. 1989). The positive induction of
aneuploidy was enhanced by coexposure to 2-butanone and nocodazole (Mayer
and Goin 1987). Although 2-butanone contains an electrophilic center at
the carbonyl carbon, further testing for genotoxicity does not seem
warranted, except in combination with other solvents. 
Reproductive Toxicity. No studies were located regarding effects on
reproductive capacity or reproductive organs and tissues in humans
following exposure to 2-butanone. The authors of a health hazard
evaluation report for NIOSH concluded that a perceived increase in the
number of spontaneous abortions among female workers believed to result
from exposure to 2-butanone and several other volatile chemicals at a shoe
factory was not related to exposure (Tharr et al. 1982). No
histopathological lesions were found in male or female reproductive organs
of rats exposed to 5,000 ppm 2-butanone for 90 days (Cavender and Casey
1981; Cavender et al. 1983), but reproductive function was not assessed.
Further studies of the reproductive function of 2-butanone by all
durations and routes would provide valuable information particularly if
the studies include histological examination of the organs and tissues of
the reproductive. system. If reproductive organs were identified as
targets of 2-butanone toxicity, single or multigeneration reproductive
studies probably would be warranted. Since 2-butanone potentiates the
neurotoxicity or hepatotoxicity of certain chemicals, it would be valuable
to investigate the reproductive effects of mixed solvent exposures that
include 2-butanone. This investigation would be useful because 2-butanone
is often found in mixtures of other solvents in occupational settings, and
these mixtures may be found together at or near hazardous waste sites.
 Developmental Toxicity. Information regarding developmental toxicity
of 2-butanone in humans was not located. 2-Butanone was slightly fetotoxic
in rats (Deacon et al. 1981; Schwetz et al. 1979) and mice (Mast et al.
1989)following inhalation exposure of pregnant rats and mice to 3,000 ppm.
The fetotoxicity was related to delayed development. Furthermore, five of
eight pregnant rats exposed continuously to 800 ppm throughout gestation
failed to deliver litters (Stoltenburg-Didinger et al. 1990). In addition, 
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developmental effects were more pronounced in pups born to rat dams
exposed to a mixture of n-hexane and 2-butanone than in pups born to dams
exposed to n-hexane alone (Stoltenburg-Didinger et al. 1990). This 
study, however, was very poorly reported, with very little information
provided on exposure to 2-butanone alone. No developmental or
distribution studies have been conducted by the oral route, but there is
no reason to believe that 2-butanone or its metabolites could not cross 
the placenta after administration by the oral route. Therefore, it is
likely that orally administered 2-butanone would be fetotoxic in these
species. Determination of the doses needed to produce the fetotoxicity by
the oral route would provide valuable information. Since 2-butanone 
potentiates the neurotoxicity or hepatotoxicity of certain chemicals, it
would be valuable to further investigage the developmental effects of
mixed solvent exposures that include 2-butanone. Such a study would be
useful because 2-butanone is often found in mixtures with other solvents 
in occupational settings, and these mixtures may be fould at or near
hazardous waste sites. 
Immunotoxicity.  No studies were located regarding immunotoxicity
after oral exposure to 2-butanone. A clinical report of contact urticaria
in a 47-year-old painter exposed occupationally to 2-butanone (Varigos and
Nurse 1986) suggests that skin sensitivity requires more study.
Altenkirch et al. (1978a) reported that 19/19 rats died suddenly of
pathologically confirmed bronchopneumonia after 7 weeks of inhalation
exposure to 6,000 ppm 2-butanone. 2-butanone may weaken the immune
system, thus predisposing humans and animals to infection. No 
histopathological lesions were found in the thymus, lymph nodes, spleen,
or bone marrow of rats exposed to 5,000 ppm or less of 2-butanone for 90
days (Cavender and Casey 1981; Cavender et al. 1983), but tests for immune
function were not performed. Therefore, a study of the effects of
2-butanone on immune function (thymus, lymph nodes, peripheral blood
lymphocytes, etc.)would provide valuable information regarding the
immunotoxicity of 2-butanone. 
Neurotoxicity.  2-butanone was not neurotoxic at a concentration of 
200 ppm in several acute inhalation exposure studies in humans (Dick et
al. 1984, 1988, 1989). Neurobehavioral effects have been observed in mice 
(1,602 ppm) )DeCeaurriz et al. 1983) and baboons (100 ppm) (Geller et al.
1979) exposed acutely by inhalation. Guinea pigs displayed narcosis and
incoordination after acute inhalation exposure to high concentrations
(Patty et al. 1935). Clinical signs of neurotoxicity were also observed
in rats treated acutely by gavage with a high dose of 2-butanone
(Stillmeadow Inc. 1978). However, 2-butanone is not generally regarded as
being highly neurotoxic when administred alone. In acute and intermediate 
exposure studies in animals, it markedly potentiated the neurotoxicity of
n-hexane and methyl-n-butyl ketone both in humans and animals. A 
comprehensive study of acute, intermdiate, and chronic exposures to
mixtures of 2-butanone, n-hexane, and methyl-n-butyl ketone by inhalation,
oral, and dermal routes will provide valuable information regarding the
neurotoxicity of these compounds. Such a study would be particularly
valuable because 2-butanone is 
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often found occupationally in mixtures containing n-hexane and methyl-n­
butyl ketone, and these chemicals would probably be found together at
hazardous waste sites. 
Epidemiological and Human Dosimetry Studies. One study with humans
etermined that inhalation exposure to 100 ppm for 15 minutes was
irritating to the nose and throat, and exposure to 350 ppm was intolerable
(Nelson et al. 1943). In three separate studies, volunteers exposed to 200
ppm had no neurobehavioral effects (Dick et al. 1984, 1988, 1989). Two
epidemiological studies of chemical company workers exposed to 2-butanone
showed inconclusive results regarding increased risk of cancer (Alderson
and Rattan 1980; Wen et al. 1985). No epidemiological studies regarding
other health effects of 2-butanone exposure were located. Therefore,
valuable epidemiological information could be obtained from further
studies of cancer and other health effects, particularly neurotoxicity and
reproductive and developmental toxicity. 
Biomarkers of Exposure and Effect. The only known biomarkers of
2-butanone exposure are blood, breath, and urinary concentrations of
2-butanone and its metabolites (Brown et al. 1986; Brugnone et al. 1983;
Ghittori et al. 1987; Miyasaka et al. 1982). 2-Butanone is rapidly cleared
from the body, and existing studies show that accumulation of 2-butanone
in tissues does not occur to a significant extent. Furthermore, 2-butanone
alone is relatively free of adverse health effects. Therefore, development
of biomarkers of exposure to a battery of solvents often used
occupationally in combination with 2-butanone would be more valuable than
development of biomarkers for 2-butanone alone. 
2-Butanone exposure has no specific effects that can be used as
biomarkers for exposure by any route or for any duration of exposure. 
Absorption, Distribution, Metabolism, and Excretion. 2-Butanone is 
absorbed by inhalation (Liira et al. 1988a, 1988b, 1990, 1991) and oral
exposure (Brown and Hewitt 1984; Dietz and Traiger 1979; Dietz et al.
1981; Hewitt et al. 1983; Sakata et al. 1989). Net retention of inhaled 2­
butanone is approximately 50% in humans (Liira et al. 1988a, 1988b).
Studies of absorption after dermal exposure would provide valuable
information on this occupationally significant route of entry. Available
data regarding the relative rates or extent of absorption, metabolism,
distribution, and excretion by the three routes of exposure are not
sufficient to draw meaningful conclusions. 2-Butanone is equally soluble
in all tissues and organs measured (Perbellini et al. 1984). Therefore, 2­
butanone is probably evenly distributed throughout the body. The primary
route of excretion appears to be the lungs. The metabolic pathways for 2­
butanone have been thoroughly studied in rats (Dietz and Traiger 1979;
Dietz et al. 1981) and guinea pigs (DiVincenzo et al. 1976). Similar
metabolites have been identified in humans (Liira et al. 1988a, 1988b;
Miyasaka et al. 1982). In rats, 30% of an oral dose of 2-butanone was
converted to 2,3-butanediol (Dietz 
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et al. 1981). Potentiation of the neurotoxicity of ethanol, n-hexane, and
methyl-n-butyl ketone and the hepatotoxicity of haloalkanes by 2-butanone
may involve interactions in the biotransformation of these compounds
(Brady et al. 1989; Cunningham et al. 1989; Raunio et al. 1990; Robertson
et al. 1989; Traiger et al. 1989). Further studies regarding the
interaction of hexacarbons, haloalkanes, and 2-butanone at the metabolic
level may provide valuable information. 
Comparative Toxicokinetics. Available human data show that 2 
butanone is metabolized primarily to 2,3-butanediol and 3-hydroxy-2­
butanone, but the extent of metabolism appears to be small (Liira et al.
1988a, 1988b). In an occupational exposure study of 2-butanone, only 3­
hydroxy-2-butanone was observed (Brugnone et al. 1983). In rats and guinea
pigs, a third metabolite, 2-butanol, was observed (Dietz et al. 1981;
DiVincenzo et al. 1976). About 30% of an oral dose of 2-butanone in rats
later appeared in plasma as 2,3-butanediol (Dietz et al. 1981). 2-Butanol
is also a product of 2-butanone metabolism in humans (Liira et al. 1990).
2-Butanone potentiates the neurotoxicity of n-hexane and methyl-n-butyl
ketone and the hepatotoxicity of haloalkanes. The 2-butanone metabolite,
2,3-butanediol, may be more efficacious for potentiating the
hepatotoxicity of the haloalkanes than 2-butanone. Therefore, valuable
information would be gained by toxicokinetic studies of 2-butanone and its
metabolites as they pertain to the toxicity of the hexacarbons and
haloalkanes. 
Mitigation of Effects. 2-Butanone by itself has a low order of
systemic toxicity. However, exposure to 2-butanone with other solvents,
which is more likely in occupational and environmental settings than is
exposure to 2-butanone alone, results in a potentiation of the
neurotoxicity and hepatotoxicity of the other solvents. Further studies
that investigate the mechanism by which 2-butanone potentiates the
toxicity of other ketones, n-hexane, chloroform, and carbon tetrachloride
would be useful in planning research aimed to develop agents that would
interfere with the mechanism, thereby mitigating the potentiation. 
2.9.3 On-going Studies
 No information regarding current studies of the health effects of
2-butanone was located. 
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3.1 CHEMICAL IDENTITY 
Data pertaining to the chemical identity of 2-butanone are listed in
Table 3-1. 
3.2 PHYSICAL AND CHEMICAL PROPERTIES 






4. PRODUCTION, IMPORT, USE, AND DISPOSAL 
4.1 PRODUCTION 
According to the most recent edition of U.S. International Trade
Commission (USITC 1989), 482,028,000 pounds of 2-butanone were produced in
the United States in 1988. The production volume for 1986 and 1987 was
600,440,000 and 671,859,000 pounds, respectively (USITC 1987, 1988). Total
U.S. capacity for 1989 has been estimated at 622 million pounds (SRI
1989). Production of 2-butanone has been flat in the past decade, but it
is expected to grow at 2%-3% through 1991 (Chemical Marketing Reporter
2987). Current manufacturers of 2-butanone are included in Table 4-1.
According to the Toxic Release Inventory (TRI 1989), 2,218 facilities
manufacture or process 2-butanone. These facilities had a maximum amount
of 2-butanone on site of approximately 1,670,000,000 pounds in 1987. These
data are presented in Table 4-2. The quality of the data must be viewed
with caution since the 1987 data represent first-time, incomplete
reporting by these facilities. Not all facilities that should have
reported have done so. 
2-Butanone is produced on a commercial scale by one of two
processes. The vapor-phase dehydrogenation of set-butanol.(2-butanol),
itself obtained from the hydrolysis of butene, accounts for 88%
2-butanone production (Neier and Strehlke 1985; Papa and Sherman 1981). In
the other commercially significant process, 2-butanone is obtained as a
byproduct of acetic acid production. In this methodology, liquified butane
is subjected to catalytic oxidation. 
4.2 IMPORT/EXPORT 
Approximately 16% of the total U.S. production of 2-butanone is
exported to other countries (Chemical Marketing Reporter 1987). Imports
into the United States amounted to about 52 million pounds in 1986. 
4.3 USE 
2-Butanone exhibits outstanding solvent properties, and combined
with its low cost, it is often the choice solvent for various coating
systems (Neier and Strehlke 1985; Papa and Sherman 1981). Uses of
2-butanone can be broken down into the following categories: coatings
solvent, 50%; adhesives, 13%; magnetic tapes, 8%; lube oil dewaxing, 4%;
printing inks, 3%; exports, 16%; and miscellaneous, 6% (Chemical Marketing
Reporter 1987). Examples of specific applications include its use as a
solvent for nitrocellulose, lacquers, rubber cement, printing inks, paint
removers, vinyl films, resins, rosins, polystyrene, chlorinated rubber,
polyurethane, acrylic coatings, and cleaning solutions (Neier and Strehlke
1985; Papa and Sherman 1981; Sax and Lewis 1987). 2-Butanone is used in
the production of synthetic leathers, transparent paper, and aluminum
foil. It is also used in the degreasing of metals, as an extraction
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4.4 DISPOSAL 
Dilute solutions of 2-butanone can be discharged directly into
sewage treatment facilities, sprayed into incinerators, or burned in paper
packaging (OHM/TADS 1989). It can be destroyed in fluidized-bed
incinerators, rotary kiln incinerators, or liquid injection incinerators
using short residence times of a few seconds for either liquids or gases,
and longer residence times for contaminated solids, if applicable (HSDB
1989). 2-Butanone has been reported to be amenable to biological
degradation in sewage treatment plants (Babeu and Vaishnav 1987; Bridie et
al. 1979; Gaudy et al. 1963.; Price et al. 1974; Urano and Kato 1986;
Vaishnav et al. 1987; Young et al. 1968). No data are available regarding
the amount disposed by each of these methods, nor is any information
available regarding the trends in the disposal of 2-butanone. 
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5.1 OVERVIEW 
2-Butanone may be released to the atmosphere in fugitive emissions
during its production, transport, and use. It is widely used in coating
systems where its volatilization to the atmosphere is an intended outcome
of its use. In urban areas, it can exist in the atmosphere as a result of
automobile exhaust, the decomposition of other organic compounds, and from
natural sources. 
The release of 2-butanone to water or soil is not well documented. 
Release of 2-butanone to surface water may occur via industrial waste
water emissions. 2-Butanone may also be released to soil or water from a
spill or other catastrophic event. The leachate of landfills and hazardous
waste sites may result in 2-butanone contamination of soil and
groundwater. 
According to the SARA Section 313 TRI (1989), an estimated total of
149,678,423 pounds of 2-butanone was released to the environment in 1987
by facilities that manufacture or process this compound. Of this,
149,478,640 pounds were released to the atmosphere. The quality of the TRI
data must be viewed with caution since the 1987 data represent first-time,
incomplete reporting of estimated releases by these facilities. Not all
sources of chemical wastes are included and not all facilities. Only
certain types of facilities were required to report. This is not an
exhaustive list. These data are presented in Table 5-1. 
2-Butanone is expected to rapidly volatilize from surface water and
moist or dry soils to the atmosphere, In the atmosphere, this compound is
expected to exist predominantly in the vapor phase. Wet deposition may
return 2-butanone to the earth's surface. 
In soil, 2-butanone is expected to display very high mobility, and
it has the potential to leach into groundwater. This characteristic also
suggests that it does not significantly adsorb to sediment and suspended
organic matter in surface waters. 2-Butanone is not expected to
bioconcentrate in fish and aquatic organisms. 
Although the degradation of 2-butanone in the environment is
understood on a theoretical level, data are not available to quantify all
conclusions. In the atmosphere, 2-butanone is expected to undergo a
vapor-phase reaction with photochemically produced hydroxyl radicals; the
half-life for this process is approximately 1 day. However, laboratory
experiments have suggested that the atmospheric half-life of 2-butanone is
much shorter. 
In water, 2-butanone is expected to undergo microbial degradation
under both aerobic and anaerobic conditions. Chemical oxidation, direct
photolysis, and hydrolysis of 2-butanone under environmental conditions
are not expected to occur to any significant extent. Data on the fate of
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Various data are available regarding the concentration of 2-butanone
in environmental media. It has been qualitatively detected in U.S. drinking
water supplies and as a naturally occurring constituent of foods. It has
also been detected in the air. 
EPA has identified 1,177 NPL sites. 2-Butanone has been found at 137
out of the sites evaluated for its presence. However, we do not know how
many of the 1,177 NPL sites have been evaluated for this chemical. As more
sites are evaluated by EPA, this number may change (View 1989). The
frequency of these sites within the United States can be seen in Figure 5-l. 
The general population is exposed to 2-butanone by drinking
contaminated water or by the ingestion of food containing it. Members of the
general population living near hazardous waste sites may be exposed to
contaminated drinking water if their household water source is well water.
The general population is also expected to be exposed to 2-butanone by
inhalation, especially in urban areas. The use of commercial coatings
containing 2-butanone also results in exposure by inhalation, and possibly
by dermal contact as well. High levels of exposure may occur for members of
the general population if these coatings are used in an enclosed,
unventilated area. Occupational exposure to 2-butanone may occur by
inhalation during the production, formulation, use, or transport of this
compound. 
5.2 RELEASES TO THE ENVIRONMENT 
5.2.1 Air 
2-Butanone may be emitted to the atmosphere during its production,
formulation, storage, or use in commercial products. 2-Butanone may also be
released to the atmosphere as a result of its use as a solvent in commercial
products. It was identified as an emission from a variety of indoor building
materials: latex caulk, particle board, latex paint, and polyurethane floor
finish (Tichenor 1987; Tichenor and Mason 1988). Since 2-butanone is
prevalent in adhesives and coatings (Papa and Sherman 1981), it may be
released to the atmosphere during the curing of these products. 
According to the SARA Section 313 TRI (1989), an estimated total of
149,478,640 pounds of 2-butanone was released to the atmosphere in 1987 by
facilities that manufacture or process this compound. The quality of the TRI
data must be viewed with caution since the 1987 data represent first-time,
incomplete reporting of estimated releases by these facilities. Only certain
types of facilities were required to report. This is not an exhaustive list. 
2-Butanone is present in the exhaust of automobiles (Seizinger and
Dimitriades 1972). In a Swedish study, 2-butanone was detected in automobile
exhaust, although the ambient air levels measured in Stockholm did not
correlate with these emissions (Jonsson et al. 1985). Thus, the prevalence
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could be explained solely by automobile emissions. Other potential sources
of 2-butanone in the atmosphere include the burning of polyethylene
(Hodgkin et al. 1982) and the photochemical degradation of hydrocarbons
(Grosjean 1982), especially those emitted from motor vehicles. 2-Butanone
is also emitted to the atmosphere from such natural sources as European
firs, junipers, cedars, cypress trees, and ferns (Isidorov et al. 1985)
and ant secretions (Cammaerts et al. 1978). 
5.2.2 Water 
Limited data are available regarding the release of 2-butanone to
surface and groundwaters. It has been detected in waste water effluents
from commercial processes (Dunovant et al. 1986; Hawthorne and Sievers
1984; Jungclaus et al. 1978; Pellizzari et al. 1979). 2-Butanone may also
be present in water from the microbial oxidation of butane (Phillips and
Perry 1974). Its relatively high water solubility, 136,000 mg/L at 25°C
(Tewari et al. 1982), suggests that wet deposition of atmospheric
2-butanone results in the contamination of surface water. Evidence for 
this comes from the fact that 2-butanone has been detected in rain water 
(Grosjean and Wright 1983).
 According to the SARA Section 313 TRI (1989), an estimated total of
75,858 pounds of 2-butanone was released to water in 1987 by facilities
that manufacture or process this compound, a very small amount compared to
what is released to the atmosphere. The quality of the TRI data must be
viewed with caution since the 1987 data represent first-time, incomplete
reporting of estimated releases by these facilities. Only certain types of
facilities were required to report. This is not an exhaustive list. 
The contamination of groundwater with 2-butanone has occurred at
hazardous waste sites (Francis et al. 1980; Sawhney and Kozloski 1984) and
landfills (Sabel and Clark 1984) due to infiltration of contaminated
leachate. 2-Butanone was detected in 180 groundwater samples from 357
hazardous waste sites monitored by the Contract Laboratory Program (CLP)
at a geometric mean concentration of 302 ppb for the positive samples
(CLPSD 1988). Note that the CLPSD includes data from both NPL and non-NPL
sites. 2-Butanone is also likely to enter groundwater as a result of a
spill to soil during a catastrophic event, such as a tanker spill
(Halvorsen and Ohneck 1985). 
2-Butanone may also enter water from natural sources. It has been
detected in various species of macroalgae at concentrations as high as
2,600 ng/g (Whelan et al. 1982). 
5.2.3 Soil 
Limited data are available regarding the release of 2-butanone to
soil. The presence of this compound in the groundwater at hazardous waste
sites and landfills (Francis et al. 1980; Sabel and Clark 1984; Sawhney
and Kozloski 1984) suggests that leachate at these facilities will be a
source of 
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2-butanone release to soil. Wet deposition of atmospheric 2-butanone may
also result in its contamination of soil. 2-Butanone may enter soil during
a catastrophic event, such as a tanker spill (Halvorsen and Ohneck 1985).
2-Butanone has been found in 309 of 357 hazardous waste sites monitored by
the CLP at a geometric mean concentration of 87 ppb (CLPSD 1988). Note
that the CLPSD includes data from both NPL and non-NPL sites.
 According to the SARA Section 313 TRI (1989), an estimated total of
48,675 pounds of 2-butanone was released to soil in 1987 by facilities
that manufacture or process this compound; a very small amount compared to
what is released to the atmosphere. The quality of the TRI data must be
viewed with caution since the 1987 data represent first-time, incomplete
reporting of estimated releases by these facilities. Only certain types of
facilities were required to report. This is not an exhaustive list. 
5.3 ENVIRONMENTAL FATE 
5.3.1 Transport and Partitioning
 In the atmosphere, 2-butanone is expected to exist predominantly in
the vapor phase (Eisenreich et al. 1981; Riddick et al. 1986). This is
consistent with experimental data, which demonstrated that the gas-phase
concentration of 2-butanone in Los Angeles, California, was from 220 to
3,000 times greater than the particulate phase concentration (Grosjean
1982). The relatively high water solubility of 2-butanone, 136,000 mg/L at
25°C (Tewari et al. 1982), suggests that wet deposition may remove 2­
butanone from the atmosphere. 2-Butanone has been identified in rain 
water (Grosjean and Wright 1983). The absence of significant amounts of
particulate 2-butanone indicates that dry deposition to the earth's
surface is not an important fate process. The short residence time
expected for 2-butanone in the atmosphere, less than 1 day,suggests that
it is not transported long distances from its original point of
release. 
Based on an experimental soil adsorption coefficient (Koc) of 3.55
(Roy and Griffin 1985) 2-butanone is expected to display very high
mobility in soil (Swann et al. 1983). 2-Butanone was found in groundwater
samples shortly after a tanker spill (Halvorsen and Ohneck 1985) and in
the groundwater underneath hazardous waste sites and public landfills
(Francis et al. 1980; Sabel and Clark 1984; Sawhney and Kozloski 1984).
The vapor pressure of 2-butanone, 90.6 mmHg at 25°C (Riddick et al. 1986),
and the Henry's law constant, 5.77x10-5 atm m3/mol at 25°C, suggest that
volatilization from either dry or moist soil to the atmosphere will be an
important environmental process. 
If 2-butanone is released to water it is expected to rapidly volatilize to
the atmosphere. Based on its Henry's law constant, an estimated
volatilization half-life from a model river 1 m deep, flowing at 1 m/set
with a wind velocity of 3 m/sec, is approximately 15 hours (Lyman et al.
1982). 
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2-Butanone is not expected to significantly adsorb to sediment and
suspended organic matter. It is also not expected to bioconcentrate in
fish and aquatic organisms (Lyman et al. 1982). These conclusions are
based on an experimental Koc of 3.55 (Roy and Griffin 1985), and a
calculated bioconcentration factor of 0.98 obtained from its octanol/water
partition coefficient, 0.29 (Hansh and Leo 1985), and an appropriate
regression equation (Lyman et al. 1982). 
5.3.2 Transformation and Degradation 
5.3.2.1 Air
 2-Butanone is expected to undergo atmospheric destruction by the
gasphase reaction with photochemically produced hydroxyl radicals. Rate 
constants for this reaction ranging from 1.85x10-11 to 9.8x10-13 
atm/molecule-sec in the temperature range of 22-32°C have appeared in the
literature (Cox et al. 1980, 1981; Edney and Corse 1986; Edney et al.
1986; Darnall et al. 1976; Gusten et al. 1984; Wallington and Kurylo 1987;
Wallington et al. 1988). Using a recommended rate constant of 1.85x10-11 
atm/molecule-sec at 25°C and an average atmospheric hydroxyl radical
concentration of 5x105 molecule/cm3 (Atkinson 1985), a half-life of 21
hours for this reaction can be calculated. However, experiments performed
under simulated atmospheric conditions in the laboratory have shown that
2-butanone has a half-life of only 9.8 hours for photo-initiated processes
(Dilling et al. 1976). The rate of its destruction increased in the
presence of other anthropogenic compounds. The atmospheric destruction of
2-butanone as a result of direct irradiation is not expected to be
significant under atmospheric conditions (Cox et al. 1980). Therefore,
direct photolysis cannot account for the enhanced rate of atmospheric
destruction observed in the laboratory. However, the data suggest that
other mechanisms are responsible for the destruction of 2-butanone in the
atmosphere, which are yet to be defined. 
5.3.2.2 Water 
2-Butanone is expected to be removed from environmental waters by
microbial degradation under both aerobic and anaerobic conditions. Limited
data specific to the chemical degradation of 2-butanone in water are
available; however, it is not expected to occur to any significant extent. 
Numerous investigations have concluded that 2-butanone undergoes
biological degradation under aerobic conditions. At an initial
concentration of 1 ppm, 2-butanone completely degraded in aerated water
obtained from a deep Florida aquifer within 14 days after a 5-day lag
period (Delfino and Miles 1985). Screening studies using a microbial seed
from domestic waste treatment plants have indicated that 2-butanone has a
5-day biological oxygen demand (BOD5) which is between 59% and 74% of the
theoretical amount after a short lag period (Babeu and Vaishnav 1987;
Bridie et al. 1979; Gaudy et al. 1963; Price et al. 1974; Urano and Kato
1986; Vaishnav et al. 1987; Young et al. 
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1968). A pure culture study indicated that propionate is produced as a
result of the microbial oxidation of 2-butanone (Phillips and Perry 1974). 
2-Butanone has been listed as a compound amenable to degradation by
anaerobic biotechnology (Speece 1983). At an initial concentration of
500 ppm, 2-butanone was completely reduced to methane within 8 days in a
fermentor using a domestic sludge inoculum that had been adapted to
acetate (Chou et al. 1979). 
An experimentally determined rate constant of 5.4x108 L/mol-sec has
been determined for the reaction of 2-butanone with hydroxyl radicals in
water (Anbar and Neta 1967). This value corresponds to a half-life of 4
years for this reaction, given a hydroxy radical concentration of 1x10-17 M 
(Mill et al. 1980). Hydrolysis of ketones is generally not believed to be
an environmentally important process (Lyman et al. 1982; Mill 1982). A
rate constant of 0 L/mol-year was listed for the hydrolysis of 2-butanone
under neutral, acidic, and basic conditions at 25°C (Kollig et al. 1987),
indicating that this process does not occur in the environment. By analogy
to the gasphase photolysis of 2-butanone (Cox et al. 1980), direct
photochemical breakdown of 2-butanone in water is not expected. Therefore,
the chemical degradation of 2-butanone in environmental waters is not
expected to occur to any significant extent. 
The chemical alteration of 2-butanone in rain water has been 
postulated. In acid rain, hydroxy sulfonates may be formed by the
reaction with bisulfite, and ammonia adducts may be formed in ammoniated
rain (Grosjean and Wright 1983). The concentration of these reactive
species is likely to be much higher in rain water than in surface water;
therefore, a more rapid rate of reaction would be expected in rain. 
5.3.2.3 Soil 
No specific data concerning the fate of 2-butanone in soil were
available. By analogy to the experimental results on the microbial
degradation of 2-butanone in water, this compound may degrade in soil
under aerobic and anaerobic conditions given suitable time for adaptation
of the microbial population. Again by using an analogy to the fate of 2­
butanone in aqueous systems, it is not expected to hydrolyze, photolyze on
the surface, or undergo chemical degradation. 
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 
5.4.1 Air
 2-Butanone has been detected in a limited number of sites in rural,
urban, and indoor locations. It was detected in 17 samples taken in
Tucson, Arizona, in 1982 at an average concentration of 2.8 ppb. In the
mountains of Arizona, the concentration was 0.50 ppb (Snider and Dawson
1985). The range 
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of 2-butanone measured in Los Angeles air in 1980 was.O-14 ppb in 70
samples (Grosjean 1982). 2-Butanone was found in one-third of samples
taken downwind of a solvent recycling facility in Maryland in 1970, at a
maximum concentration of 94 ppm (Smoyer et al. 1971). Although it has been
detected in the exhaust of gasoline engines, it was not found in the air
of a highway mountain tunnel (Hampton et al. 1982).
 2-Butanone was detected in the air of the Kin-But chemical waste 
site, located in New Jersey, at concentrations ranging from trace to 1.5
pg/m3 (0.51 ppb), and 0.5 to 33 µg/m3 (0.17-11.3 ppb) in samples
surrounding the site (Pellizzari 1982). It was qualitatively detected in
the air at four of four hazardous waste sites and one landfill in New 
Jersey (LaRegina et al. 1986).
 In a survey of 36 homes taken in Chicago, Illinois, 2-butanone was
detected in the indoor air at 3 residences (Jarke et al. 1981). It was
also found in three outdoor samples in this survey. It is not clear,
however, if the positive indoor and outdoor samples were collected at the
same location. In a compilation and analysis of ambient monitoring data
collected from 1970 to 1987, the daily concentration of 2-butanone was 0
ppb in urban, suburban, and rural areas (Shah and Heyerdahl 1988). 2­
Butanone has been qualitatively detected in the indoor air of homes in
Chicago (Jarke et al. 1981) and in Canadian residential and office
buildings (Tsuchiya 1987).
 The sporadic ambient air monitoring data available for 2-butanone
suggest that the average background concentration of this compound may be
very low. However, the available data also suggest that there are
dramatic, temporal, and diurnal variations in its concentration. 
5.4.2 Water
 Numerous studies have qualitatively detected 2-butanone in drinking 
water supplies (Kool et al. 1982). It has been found in drinking water 
from the District of Columbia; Cincinnati, Ohio; Miami, Florida; Ottumwa,
Iowa; Philadelphia, Pennsylvania; Seattle, Washington; Tuscaloosa,
Alabama; and New Orleans, Louisiana (Bertsch et al. 1975; Coleman et al.
1976; EPA 1974, 1975; Kopfler et al. 1977; Scheiman et al. 1974). It was
detected in Des Moines, Iowa, drinking water samples at an estimated
concentration of 1.6 ppb (Ogawa and Fritz 1985). 2-Butanone was detected
in tap water 8 months after the installation of new polyvinyl chloride
(PVC) pipes at a concentration ranging from 0.4 to 4.5 ppm (Wang and
Bricker 1979). It resulted from the glue used to cement the water pipes
together. The concentration of 2-butanone in the water increased with the
amount of time the water sat in the pipes. 
2-Butanone has been qualitatively detected in rain water and the
clouds of Henninger, California, at 0.04 ppb, and in the mist of Long
Beach, California (Grosjean and Wright 1983). Trace amounts have also been
found in the ice in Fairbanks, Alaska (Grosjean and Wright 1983). 
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2-Butanone was listed as being detected in less than 5% of U.S.
groundwater supplies (Dyksen and Hess 1982). At U.S. hazardous waste
sites, 2-Butanone was listed as being frequently detected in the
groundwater (Garman et al. 1987). This statement should be interpreted
with caution, as "frequently" was defined as greater than 0.1%, of the
samples. 2-Butanone was detected in 180 groundwater samples from 357
hazardous waste sites monitored by the CLP at a geometric mean
concentration of 302 ppb in the positive samples (CLPSD 1988). Examples
of.the presence of 2-butanone at hazardous waste sites and landfills can
be found in Table 5-2. It was detected in groundwater samples underneath a
tanker truck spill at concentrations up to 2,200 ppm (Halvorsen and Ohneck
1985). Interpretation of the concentration of 2-butanone found in
groundwater samples should be made carefully, and should take into account
the experimental methods used in the determinations; results
may be skewed due to the presence of 2-butanone in the adhesives used to
cement PVC well pipes together (Sosebee et al. 1983).
 2-Butanone has been detected in the effluent of various industrial 
processes. It was found in six of seven waste water samples from
energyrelated processes at a concentration up to 645 ppb (Pellizzari et
al. 1979). 2-Butanone was detected in the waste water of a specialty
chemical manufacturing plant at a concentration of 8-20 ppm, but not in
the receiving river water or its sediment (Jungclaus et al. 1978). It was
also detected in the waste water from shale oil processing at a
concentration of 0.4-18 ppm (Hawthorne and Sievers 1984).In 1982, 2­
butanone was detected at concentrations of 83 ppb or less in the waste
water entering Cincinnati treatment plants (Dunovant et al. 1986). 
2-Butanone has been detected in 77 of 357 surface water samples at
U.S. hazardous waste sites at a geometric mean concentration of 11 ppb for
the positive samples (CLPSD 1988). It was qualitatively detected in the
Black Warrier River, located in Tuscaloosa, Alabama (Bertsch et al. 1975),
and in sea water from the straits of Florida at O-22 ppb in 1968 (Corwin
1969). 
5.4.3 Soil
 Limited data are available on the detection of 2-butanone in soil 
samples. It has been found in 309 of 357 hazardous waste sites monitored
by the CLP at a geometric mean concentration of 87 ppb for the positive
samples (CLPSD 1988). 
5.4.4 Other Environmental Media 
2-Butanone has been detected as a natural component of numerous
types of foods. It has been qualitatively identified as a volatile
constituent in raw chicken breast muscle, milk, roasted filberts (nuts),
Beaufort (Gruyere) and cheddar cheese, bread dough, and intact tree-
ripened nectarines (Dumont and Adda 1978; Gordon and Morgan 1979; Grey and
Shrimpton 1967; Keen et al. 1974; 
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Kinlin et al. 1972; Sosulski and Mahmoud, 1979; Takeoka 'et al. 1988). The
mean concentration of 2-butanone in dried beans, split peas, and lentils
was 148, 110, and 50 ppm, respectively (Lovegren et al. 1979). 2-Butanone
has been detected in southern peas at a median concentration of 120 ppb
(Fisher et al. 1979), and it has been qualitatively detected in winged
beans and soybeans (Del Rosario et al. 1984). It has also been detected in
cigarette smoke (Higgins et al. 1983; Osborne et al. 1956). 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
 Available monitoring data suggest that the general population is
exposed to 2-butanone. In the early stages of the Total Exposure
Assessment Methodology (TEAM) study, 2-butanone was qualitatively detected
in 3 of 8 personal air samples, 5 of 12 breath samples, and 1 of 1
drinking water sample obtained from 12 volunteers living in urban areas of
New Jersey or North Carolina (Wallace et al. 1984). 2-Butanone has also
been detected in the expired air of 206 of 387 samples (53.2%) taken from
54 adult, nonsmoking, urban dwelling subjects, at an average concentration
of 3.6 ng/L (Krotoszynski et al. 1979). It was detected in the expired air
of six of eight male volunteers, three of whom were smokers (Conkle et al.
1975). 2-Butanone was found in 5 of 12 samples of human mothers' milk from
subjects in 4 different U.S. urban areas (Pellizzari et al. 1982). It has
been qualitatively detected in the indoor air of homes in Chicago (Jarke
et al. 1981) and in Canadian residential and office buildings (Tsuchiya
1987).
 Exposure to 2-butanone by the general population may occur by
ingestion of contaminated drinking water. This compound has been
identified in U.S. drinking water supplies (Bertsch et al. 1975; Coleman
et al. 1976; EPA 1974, 1975; Kopfler et al. 1977; Ogawa and Fritz 1985;
Scheiman et al. 1974). Inhalation is also a likely route of exposure to 2­
butanone, especially during the household use of commercial coatings that
use 2-butanone as a solvent. Exposure by dermal contact may also occur
during the use of such coatings.
 2-Butanone is a naturally occurring constituent in a variety of
common foods (Del Rosario et al. 1984; Dumont and Adda 1978; Gordon and
Morgan 1979; Grey and Shrimpton 1967; Keen et al. 1974; Kinlin et al.
1972; Lovegren et al. 1979; Takeoka et al. 1988). Ingestion of these foods
will result in exposure to 2-butanone. Exposure to 2-butanone may also
occur while smoking (Higgins et al. 1983; Osborne et al. 1956). Students
taking undergraduate general chemistry laboratory courses may be also
exposed to 2-butanone (Kolb 1988).
 According to the National Occupational Exposure Survey (NOES)
conducted by NIOSH between 1980 and 1983, 1,221,587 workers, of which
201,308 were women, were potentially exposed to 2-butanone during that
time period (NIOSH 1989). Of these workers, 84% (80% for the women) were
exposed during the use of trade name products containing 2-butanone.
Occupational exposure is expected to occur by inhalation and dermal
contact. 
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A study of three companies involved in spray painting and spray
gluing operations reported that, for 89 workers exposed to 2-butanone, the
mean air concentration was 0.3 ppm (Whitehead et al. 1984). 2-Butanone was
detected in the air of Cincinnati waste water treatment plants in 1982; 3
of 17 samples were positive at concentrations of 5.7 ppb or less (Dunovant
et al. 1986). It has also been detected in the air above shale oil waste
waters (Hawthorne and Sievers 1984). The breathing zone air for workers at
an organic solvent recycling plant averaged 11 ppm during drum decantation
operations, and 10 ppm during all other work activities (Kupferschmid and
Perkins 1986). The ambient concentration was not greater than exposure
limits of 200 ppm in any of these examples (NIOSH 1984). The
concentrations of 2-butanone in air samples obtained from the Skylab,
1973-74, ranged from 2.4 to 1,505 ppb (Liebich et al. 1975). Personal
exposure to 2-butanone at a waste solvent incineration facility ranged
from <O.Ol to 1.2 ppm (Decker et al. 1983). 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 
For the general population, high levels of exposure to 2-butanone
may occur for those living near commercial settings where this compound is
used. For example, the downwind 2-butanone concentration near a solvent
recycling facility was measured at concentrations up to 94 ppm (Smoyer et
al. 1971). High levels of exposure may also occur during the use of
commercial coatings containing 2-butanone, especially when working in
enclosed, unventilated spaces. Members of the general population living
near hazardous waste sites and drawing their drinking water from
groundwater sources may be exposed to high levels of 2-butanone through
ingestion of contaminated water, although no information on the size of
the population can be provided. 
High levels of occupational exposure to 2-butanone may occur by inhalation
and dermal contact during the loading and unloading of large quantities of
this material during shipment. The application of commercial coatings
containing 2-butanone without adequate protection may also lead to high
levels of exposure, primarily by inhalation. 
5.7 ADEQUACY OF THE DATABASE 
Section 104(i)(5) of CERCLA as amended directs the Administrator of ATSDR
(in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on
the health effects of 2-butanone is available. Where adequate information
is not available, ATSDR, in conjunction with the National Toxicology
Program (NTP), is required to assure the initiation of a program of
research designed to determine the health effects (and techniques for
developing methods to determine such health effects) of 2-butanone. 
The following categories of possible data needs have been identified by a
joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or 
eliminate 
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the uncertainties of human health assessment. In the future, the
identified data needs will be evaluated and prioritized, and a substance-
specific research agenda will be proposed. 
5.7.1 Data Needs 
Physical and Chemical Properties. The physical and chemical
properties of 2-butanone are well documented. The environmental fate of 2­
butanone can be predicted from these properties and compared to
experimental results once they are obtained in areas where deficiencies
exist. 
Production, Import/Export, Use, and Disposal. The significant
amounts of 2-butanone produced in the United States, combined with its
prevalence in commercial and household products, suggest that large
numbers of citizens are potentially exposed to,anthropogenic sources of
this $ompound. The production, use, and international trading of 2­
butanone is well described in the available literature (Chemical Marketing
Reporter 1987; Neir and Strehlke 1985; Papa and Sherman 1981; USITC 1987,
1988, 1989). Methods for the disposal of 2-butanone are established (HSDB
1989; OHM/TADS 1989), but the amounts processed by each method cannot be
ascertained. Therefore, disposal of 2-butanone cannot be compared to the
regulations controlling this practice. Knowing the amount of 2-butanone
released to the environment and its disposal pattern will aid in
determining routes and levels of exposure to the general population by
indicating which media should be monitored carefully. 
According to the Emergency Planning and Community Right-to-Know Act
of 1986, 42 U.S.C. Section 11023, industries are required to submit
chemical release and off-site transfer information to EPA. The Toxic 
Release Inventory (TRI), which contains this information for 1987, became
available in May of 1989. This database will be updated yearly and should
provide a list of industrial production facilities and emissions. 
Environmental Fate. There is sufficient predictive information to
indicate that 2-butanone is not likely to partition from water (Hansch and
Leo 1985; Lyman et al. 1982; Roy and Griffen 1985); yet, there are few
field studies to verify these predictions. Similarly, 2-butanone's
transport, transformation, and degradation in the environment can be
predicted (Atkinson 1985; Babeu and Vaishnav 1987; Cox et al. 1980;
Delfino and Miles 1985), but not as yet experimentally substantiated in
all areas. Experimental studies in this area would allow the determination
of 2-butanone's lifetime in the environment and aid in determining levels
and routes of human exposure.
 Bioavailability from Environmental Media. Numerous toxicokinetic and 
toxicity studies in humans and animals have demonstrated the
bioavailability of 2-butanone from air, ingestion of food and water, and
dermal contact. Absorption of 2-butanone after inhalation is well
established, and it appears to be adsorbed after ingestion. These
mechanisms are consistent with what one would expect, based on 2­
butanone's physical and chemical properties (Lyma 
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et al. 1982). Given the potential for exposure to 2-butanone because of
its prevalence in commercial products available to the public (Neier and
Strehlke 1985) and its ability to enter the immediate areas of the
environment (TRI 1989), further research on the bioavailability of this
compound will allow the quantification of human exposure and risk. 
Food Chain Bioaccumulation. 2-Butanone is not believed to 
appreciably bioconcentrate in fish and aquatic organisms (Hansch and Leo
1985; Lyman et al. 1982). It is also not expected to biomagnify in the
food chain. Quantitative data supporting these conclusions are not
available in the literature. Additional information on bioconcentration 
and biomagnification would be useful in confirming the predicted behavior
of this compound.
 Exposure Levels in Environmental Media. Data are available regarding
the level of 2-butanone in endronmental media (Grosjean and Wright 1983;
Shah and Heyerdahl 1988) and foods (Dumont and Adda 1978; Grey and
Shrimpton 1967; Kinlin et al. 1972; Lovegren et al. 1979; Takeoka et al.
1988); however, the data available are often qualitative and only
generalized trends regarding the occurrence of this compound can be
derived. Its presence in environmental media near hazardous waste sites is
not well documented (CLPSD 1988). Quantitative determination of the
levels of 2-butanone in environmental media and foods will allow the 
estimation of levels on human intake of this compound from each media. 
Exposure Levels in Humans. 2-Butanone has been found in the human 
blood samples of urban dwellers, but the observed levels have not been
correlated with personal activities. Studies on the level of 2-butanone in
human tissues near hazardous waste sites are not complete. A correlation
of the levels of 2-butanone in humans with their personal activities or
the areas where they live will allow an assessment of potential exposure
to the general population. Similarly, correlations of occupational
exposure by profession will allow a determination of human exposure
levels.
 Exposure Registries. No exposure registries for 2-butanone were
located. This compound is not currently one of the compounds for which a
subregistry has been established in the National Exposure Registry. The
compound will be considered in the future when chemical selection is made
for subregistries to be established. The information that is amassed in
the National Exposure Registry facilitates the epidemiological research
needed to assess adverse health outcomes that may be related to the
exposure to the compound. 
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5.7.2 On-going Studies 
On-going studies on water purification techniques and transformation
of 2-butanone in the environment have been identified (EPA 1989b),
although no specific information was provided. 
As part of the Third National Health and Nutrition Evaluation Survey
(NHANES III), the Environmental Health Laboratory Sciences Division of the
Center for Environmental Health and Injury Control, Centers for Disease
Control, will be analyzing human blood samples for 2-butanone and other
volatile organic compounds. These data will give an indication of the




6. ANALYTICAL METHODS 
The purpose of this chapter is to describe the analytical methods
that are available for detecting and/or measuring and monitoring
2-butanone in environmental media and in biological samples. The intent is
not to provide an exhaustive list of analytical methods that could be used
to detect and quantify 2-butanone. Rather, the intention is to identify
well-established methods that are used as the standard methods of 
analysis. Many of the analytical methods used to detect 2-butanone in
environmental samples are the methods approved by federal agencies such as
EPA and the National Institute for Occupational Safety and Health (NIOSH).
Other methods presented in this chapter are those that are approved by
groups such as the Association of Official Analytical Chemists (AOAC) and
the American Public Health Association (APHA). Additionally, analytical
methods are included that refine previously used methods to obtain lower
detection limits, and/or to improve accuracy and precision. 
6.1 BIOLOGICAL MATERIALS 
Numerous procedures that detect-2-butanone in biological materials
have been reported in the literature. A summary of.these methods is found
in Table 6-l. In general, each technique appears to be capable of
determining 2-butanone in any type of biological matrix given suitable
modification of the sample collection/preparation step. 
Since 2-butanone is a volatile compound, analysis by headspace
sampling can be accomplished for both liquid matrices, such as blood and
urine (Deveaus and Huvenne 1987; Perbellini et al. 1984), and solid
matrices, such as soft tissue (Perbellini et al. 1984). For solid samples
such as soft tissue, better results are obtained if the sample is first
homogenized at low temperatures before analysis. The technique involves
gently heating the sample in a closed system, followed by withdrawing a
portion of the air above the sample (the headspace) by syringe. Separation
of 2-butanone from other compounds that may be present is then
accomplished by injecting the contents of the syringe directly into a gas
chromatograph (GC). As indicated in Table 6-2, successful quantification
of 2-butanone has been accomplished using a variety of detection systems,
including a flame ionization detector, mass spectrometer, or Fourier
transform infrared spectrometer. 
Analysis of 2-butanone in liquid samples can also be accomplished by
purge and trap methodology (Pellizzari et al. 1982). In this technique, an
inert gas is bubbled through the sample, liberating 2-butanone. The
contaminant is then trapped on an adsorbent cartridge, followed by thermal
desorption directly into a gas chromatograph (GC). This technique has been
successfully used for analysis of human milk samples (Pellizzari et al.
1982) 
Extractive techniques can also be used for the analysis of 2­
butanone in liquid samples (Kezic and Monster 1988; Van Doorn et al.
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After concentrating the extract, the sample can be analyzed by different
methods. 2-Butanone can first be derivitized to increase its extraction 
efficiency, or to make it more visible to the detection system. 
Numerous types of detection and quantitation methods have been used
in the analysis of 2-butanone in biological samples. Gas chromatography
has been used to separate 2-butanone from other contaminants that may be
present. Direct quantitation can be made by using a flame ionization
detector (FID), tandem gas chromatography-mass spectrometry (GC-MS), or
tandem GC-fourier transform infrared spectrometry (GC-FTIR). The latter
two techniques also allow direct identification of the contaminants.
Analysis of derivitized 2-butanone can be accomplished using high-
performance liquid chromatography (HPLC) equipped with an ultraviolet (WV)
detector. These detection systems are capable of measuring 2-butanone in
the sub-ppm range; the limits on the GC-FTIR system are slightly greater
than 1 ppm. 
Given the numerous techniques available for the determination of
2-butanone in biological samples, and the lack of any standardized method
for each individual matrix, the choice of an analysis technique appears to
be a function of the instrumentation and personal biases of the laboratory
performing the analysis. With the exception of the derivitization method,
all of the techniques described above are also capable of determining the
metabolites of 2-butanone (3-hydroxy-2-butanone, 2-butanol, and 2,3­
dihydroxybutane) in biological samples. 
6.2 ENVIRONMENTAL SAMPLES 
A short description of standardized methods that can be used for the
analysis of 2-butanone in environmental samples is presented in Table 6-2.
It should be noted that an extensive list of methods for the analysis of
2-butanone in environmental samples can be compiled from the literature.
In all of these methods, however, there is a consensus that, after the
sample preparation stage, mixture separation and quantitative analysis are
best determined by the use of a gas chromatograph coupled with any of an
assortment of detectors (Bertsch et al. 1975; Coleman et al. 1976; Corwin
1969; Dunovant et al. 1986; Hawthorne and Sievers 1984; Isidorov et al.
1985; Jonsson et al. 1985; Jungclaus et al. 1978; LaRegina et al. 1986;
Pellizzari 1982; Sawhney and Kozloski 1984; Smoyer et al. 1971; Snider and
Dawson 1985; Wallace et al. 1984; Wang and Bricker 1979).
 The analysis of 2 butanone in air can be accomplished by NIOSH method
2500 (NIOSH 1984). The sample is obtained in the field by the use of a
pumping system to pass a measurable quantity of air (approximately l-12 L)
through a tube loaded with a solid sorbent, Ambersorb XE-347. Extraction
of the tube with the solvent carbon disulfide liberates the 2-butanone,
and quantitation is achieved by GC using a flame ionization detector. 
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The analysis of 2-butanone in soil, sediment, and water samples at
hazardous waste sites is described in the Contract Laboratory Program
manual (EPA 1988). For the soil and sediment samples, the procedure begins
with the addition of a small portion of water to the sample. At this
point, all three matrices are subjected to a purge and trap cycle. An
inert gas is bubbled through the sample, volatilizing 2-butanone. The gas
stream is then passed through an adsorbent tube that recollects the 2­
butanone. The sorbent tube is attached to a gas chromatograph and heated
to flush the sample onto a GC column. Quantification can be accomplished
using either a flame ionization detector or a mass spectrometer, depending
on the total concentration of organics in the sample. Required
quantitation limits for this program are 10 ppm in all three matrices. No
other standardized methods for the determination of 2-butanone in 
environmental samples were located. 
6.3 ADEQUACY OF THE DATABASE
 Section 104(i)(5) of CERCLA as amended directs the Administrator of
ATSDR in consultation with the Administrator of EPA and agencies and
programs of the Public Health Service) to assess whether adequate
information on the health effects of 2-butanone is available. Uhere 
adequate information is not available, ATSDR, in conjunction with the
National Toxicology Program (NTP), is required to assure the initiation of
a program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of
2-butanone.
 The following categories of possible data needs have been identified
by a joint team of scientists from ATSDR, NTP, and EPA. They are defined
as substance-specific informational needs that, if met, would reduce or
eliminate the uncertainties of human health assessment. In the future, the
identified data needs will be evaluated and prioritized, and a substance-
specific research agenda will be proposed. 
6.3.1 Data Needs
 Methods for Determining Biomarkers of Exposure and Effect. Numerous 
methods for the determination of 2-butanone in biological materials have
been described in the literature (Deveaux and Huvenne 1987; Kezic and
Monster 1988; Pellizzari et al. 1982; Perbellini et al. 1984; Van Doorn et
al. 1989). These methods are also appropriate for determining the
metabolites of 2-butanone, 3-hydroxy-2-butanone, 2-butanol, and 2,3­
dihydroxybutane, which also serve as biomarkers of exposure. These methods
display the requisite sensitivity to measure background levels in the
population and levels which may indicate a concern for biological effects.
Standardized methods for these procedures should be established as no
standardized methods could be located. Any methodology established for
determining biomarkers of exposure must take into account the short
biological half-life of 2-butanone, which may render these methods
inferior to direct measurements of exposure. 
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There are no known biomarkers of effect which are specific to 2-butanone. 
Methods for Determining Parent Compounds and Degradation Products in
Snvironmental Media. Numerous methods capable of detecting low levels of
2-butanone in environmental media have been described in the literature 
(Bertsch et al. 1975; Dunovant 1985; Hawthorne and Sievers 1984; LaRegina
et al. 1986; Pellizzari 1982; Wallace et al. 1984). Appropriate
standardized methods are available for the determination of 2-butanone in 
air (NIOSH 1984), water, soil, and sediments (EPA 1988) at levels that may
constitute a concern for human health. The methods for determining 2­
butanone in air, the medium that represents the most concern for exposure,
are highly sensitive, accurate, and reproducible. The exact levels of
detection for these methods in all media, however, are not described.
There are numerous reliable methods available in the literature that have 
been used to determine levels of 2-butanone in environmental media and 
foods at levels that may cause health effects to occur, but they have not
been standardized. 
6.3.2 On-going Studies 
The Environmental Health Laboratory Sciences Division of the Center
for Environmental Health and Injury Control, Centers for Disease Control,
is developing methods for the analysis of 2-butanone and other volatile
organic compounds in blood, These methods use purge and trap methodology
and magnetic sector mass spectrometry which gives detection limits in the
low parts per trillion range.
 On-going studies involving the development of analytical methods
have been identified (EPA 1989b), although no specific information was
provided. 
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7. REGULATIONS AND ADVISORIES
 International (World Health Organization) guidelines for 2-butanone
were not located. National and state regulations and guidelines pertinent
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or
less, as specified in the Toxicological Profiles. 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical 
adsorbed per unit weight of organic carbon in the soil or sediment to the
concentration of the chemical in solution at equilibrium. 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment
or soil (i.e., the solid phase) divided by the amount of chemical in the
solution phase, which is in equilibrium with the solid phase, at a fixed
solid/solution ratio. It is generally expressed in micrograms of chemical
sorbed per gram of soil or sediment. 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a
chemical in aquatic organisms at a specific time or during a discrete time
period of exposure divided by the concentration in the surrounding water
at the same time or during the same period. 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or
group of studies, that produces significant increases in the incidence of
cancer (or tumors) between the exposed population and its appropriate
control. 
Carcinogen -- A chemical capable of inducing cancer. 
Ceiling Value -- A concentration of a substance that should not be 
exceeded, even instantaneously. 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as
specified in the Toxicological Profiles. 
Developmental Toxicity -- The occurrence of adverse effects on the 
developing organism that may result from exposure to a chemical prior to
conception (either parent), during prenatal development, or postnatally to
the time of sexual maturation. Adverse developmental effects may be
detected at any point in the life span of the organism. 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a
result of prenatal exposure to a chemical; the distinguishing feature
between the two terms is the stage of development during which the insult
occurred. The terms, as used here, include malformations and variations,
altered growth, and in utero death. 
EPA Health Advisory -- An estimate of acceptable drinking water levels for
a chemical substance based on health effects information. A health 
advisory is not a legally enforceable federal standard, but serves as
technical guidance to assist federal, state, and local officials. 
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Immediately Dangerous to Life or Health (IDLH) -- The maximum 
environmental concentration of a contaminant from which one could escape
within 30 min without any escape-impairing symptoms or irreversible health
effects. 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364
days as specified in the Toxicological Profiles. 
Immunologic Toxicity -- The occurrence of adverse effects on the immune 
system that may result from exposure to environmental agents such as
chemicals. 
In vitro -- Isolated from the living organism and artificially maintained,
as in a test tube. 
In vivo -- Occurring within the living organism. 
Lethal Concentration (Lo)(LC(Lo) -- The lowest concentration of a chemical in 
air which has been reported to have caused death in humans or animals. 
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical 
in air to which exposure for a specific length of time is expected to
cause death in 50% of a defined experimental animal population. 
Lethal Dose(Lo) (LDLo) -- The lowest dose of a chemical introduced by a
route other than inhalation that is expected to have caused death in
humans or animals. 
Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated 
to cause death in 50% of a defined experimental animal population. 
Lethal Time(50) (LT(50)) -- A calculated period of time within which a
specific concentration of a chemical is expected to cause death in 50% of
a defined experimental animal population. 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of 
chemical in a study, or group of studies, that produces statistically or
biologically significant increases in frequency or severity of adverse
effects between the exposed population and its appropriate control. 
Malformations -- Permanent structural changes that may adversely affect
survival, development, or function. 
Minimal Risk Level -- An estimate of daily human exposure to a chemical
that is likely to be without an appreciable risk of deleterious effects
(noncancerous) over a specified duration of exposure. 
Mutagen -- A substance that causes mutations. A mutation is a change in
the genetic material in a body cell. Mutations can lead to birth defects,
miscarriages, or cancer. 
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Neurotoxicity -- The occurrence of adverse effects on the nervous 
system following exposure to chemical. 
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at 
which there were no statistically or biologically significant
increases in frequency or severity of adverse effects seen between the
exposed population and its appropriate control. Effects may be
produced at this dose, but they are not considered to be adverse. 
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of
the concentrations of a chemical in n-octanol and water, in dilute
solution. 
Permissible Exposure Limit (PEL) -- An allowable exposure level in
workplace air averaged over an 8-hour shift. 
q1*-- The upper-bound estimate of the low-dose slope of the dose-
response curve as determined by the multistage procedure. The ql* can 
be used to calculate an estimate of carcinogenic potency, the
incremental excess cancer risk per unit of exposure (usually ug/L for
water, mg/kg/day for food, and µg/m3 for air). 
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps
an order of magnitude) of the daily exposure of the human population
to a potential hazard that is likely to be without risk of deleterious
effects during a- lifetime. The RfD is operationally derived from the
NOAEL (from animal and human studies) by a consistent application of
uncertainty factors that reflect various types of data used to
estimate RfDs and an additional modifying factor, which is based nn a
professional judgment of the entire database on the chemical. The RfD
are not applicable to nonthreshold effects such as cancer. 
Reportable Quantity (RQ) -- ,The quantity of a hazardous substance
that is considered reportable under CERCLA. Reportable quantities are
(1) 1 lb or greater or (2) for selected substances, an amount
established by regulation either under CERCLA or under Sect. 311 of
the Clean Water Act. Quantities are measured over a 24-hour period. 
Reproductive Toxicity -- The occurrence of adverse effects on the 
reproductive system that may result from exposure to a chemical. The
toxicity may bedire.cted to the reproductive organs and/or the related
endocrine system. The manifestation of such toxicity may be noted as
alterations in sexual behavior, fertility, pregnancy outcomes, or
modifications in other functions that are dependent on the integrity
of this system. 
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Short-Term Exposure Limit (STEL) -- The maximum concentration to which 
workers can be exposed for up to 15 min continually. No more than four
excursions are allowed per day, and there must be at least 60 min between
exposure periods. The daily TLV-TWA may not be exceeded. 
Target Organ Toxicity -- This term covers a broad range of adverse effects
on target organs or physiological systems (e.g., renal, cardiovascular)
extending from those arising through a single limited exposure to those
assumed over a lifetime of exposure to a chemical. 
Teratogen -- A chemical that causes structural defects that affect the 
development of an organism: 
Threshold Limit Value (TLV) -- A concentration of a substance to which 
most workers can be exposed without adverse effect. The TLV may be
expressed as a TWA, as a STEL, or as a CL. 
Time-Weighted Average (TWA) -- An allowable exposure concentration
averaged over a normal 8-hour workday or 40-hour workweek. 
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route
other than inhalation, which is expected to cause a specific toxic effect
in 50% of a defined experimental animal population. 
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD
from experimental data. UFs are intended to account for (1) the variation
in sensitivity among the members of the human population, (2) the
uncertainty in extrapolating animal data to the case of human, (3) the
uncertainty in extrapolating from data obtained in a study that is of less
than lifetime exposure, and (4) the uncertainty in using LOAEL data rather





Public Health Statement 
This chapter of the profile is a health effects summary written in
nontechnical language. Its intended audience is the general public
especially people living in the vicinity of a hazardous waste site or
substance release. If the Public Health Statement were removed from the 
rest of the document, it would still communicate to the lay public
essential information about the substance. 
The major headings in the Public Health Statement are useful to find
specific topics of concern. The topics are written in a question and
answer format. The answer to each question includes a sentence that will
direct the reader to chapters in the profile that will provide more
information on the given topic. 
Chapter 2 
Tables and Figures. for Levels of Significant Exposure (LSE) 
Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize
health effects by duration of exposure and endpoint and to illustrate
graphically levels of exposure associated with those effects. All entries
in these tables and figures represent studies that 'provide reliable,
quantitative estimates of No-Observed-Adverse-Effect Levels (NOAELs),
Lowest-Observed- Adverse-Effect Levels (LOAELS) for Less Serious and
Serious health effects, or Cancer Effect Levels (CELs). In addition, these
tables and figures illustrate differences in response by species, Minimai
Risk Levels (MRLs) to humans for noncancer end points, and EPA's estimated
range associated with an upper-bound individual lifetime cancer risk of 1
in 10,000 to 1 in 10,000,000. The LSE tables and figures can be used for a
quick review of the health effects and to locate data for a specific
exposure scenario. The LSE tables and figures should always be used in
conjunction with the text. 
The legends presented below demonstrate the application'of these tables
and figures. A representative example of LSE Table 2-1 and Figure 2-l are
shown. The numbers in the left column of the legends correspond to the
numbers in the example table and figure. 
LEGEND 
See LSE Table 2-l 
1) Route of Exposure One of the first considerations when reviewing the
toxicity of a substance using these tables and figures should be the




three LSE tables and two LSE figures are presented in the document.
The three LSE tables present data on the three principal routes of
exposure, i.e., inhalation, oral, and dermal (LSE Table 2-1, 2-2,
and 2-3, respectively). LSE figures are limited to the inhalation
LSE Figure 2-1) and oral (LSE Figure 2-2) routes. 
(2)	 Exposure Duration Three exposure periods: acute (14 days or less);
intermediate (15 to 364 days); and chronic (365 days or more) are
presented within each route of exposure. In this example, an
inhalation study of intermediate duration exposure is reported. 
(3)	 Health Effect The major categories of health effects included in
LSE tables and figures are death, systemic, immunological,
neurological, developmental, reproductive, and cancer. NOAELs and
LOAELs can be reported in the tables and figures for all effects but
cancer.- Systemic effects are further defined in the "System" column
of the LSE table. 
(4)	 Key to Figure Each key number in the LSE table links study
information to one or more data points using the same key number in
the corresponding LSE figure. In this example, the study represented
by key number 18 has been used to define a NOAEL and a Less Serious
LOAEL (also see the two “18r” data points in Figure 2-l). 
(5)	 Species The test species, whether animal or human, are identified in
this column. 
(6)	 Exposure Freauency/Duration The duration of the study and the weekly
and daily exposure regimen are provided in this column. This permits
comparison of NOAELs and LOAELs from different studies. In this case
(key number 18), rats were exp'osed to [substance x] via inhalation
for 13 weeks, 5 days per week, for 6 hours per day. 
(7)	 System This column further defines the systemic effects. These 
systems include: respiratory, cardiovascular, gastrointestinal, 
hematological, musculoskeletal, hepatic, renal, and dermal/ocular. 
"Other" refers to any systemic effect (e.g., a decrease in body 
weight) not covered in these systems. In the example of key number 
18, one systemic effect (respiratory) was investigated in this 
study. 
(8)	 NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest
exposure level at which no harmful effects were seen in the organ
system studied. Key number 18 reports a NOAEL of 3 ppm for the
respiratory system which was used to derive an intermediate
exposure, inhalation MRL of 0.005 ppm (see footnote Wc"). 
(9)	 LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest
exposure level used in the study that caused a harmful health
effect. LOAELs have been classified into "Less Serious" and 
"Serious" effects. These distinctions help readers identify the
levels of exposure at which adverse health effects first appear and
the gradation of effects with increasing dose. A brief description







quantify the adverse effect accompanies the LOAEL. The "Less
Serious" respiratory effect reported in key number 18 (hyperplasia)
occurred at a LOAEL of 10 ppm. 
(10) Reference The complete reference citation is given in Chapter 8 of
the profile. 
(11) CEL A Cancer Effect Level (CEL) is the lowest exposure level
associated with the onset of carcinogenesis in experimental or
epidemiological studies. CELs are always considered serious effects.
The LSE tables and figures do not contain NOAELs for cancer, but the
text may report doses which did not cause a measurable increase in
cancer. 
(12) Footnotes Explanations of abbreviations or reference notes for data
in the LSE tables are found in the footnotes. Footnote "c" indicates 
the ppm in key number 18 was used to derive an MRL of 0.005 ppm. 
LEGEND 
See LSE Figure 2-1 
LSE figures graphically illustrate the data presented in the corresponding
LSE tables. Figures help the reader quickly compare health effects
according to exposure levels for particular exposure duration. 
(13). Exposure Duration The same exposure periods appear as in the LSE
table. In this example, health effects observed within the
intermediate and chronic exposure periods are illustrated. 
(14). Health Effect These are the categories of health effects for which
reliable quantitative data exist. The same health effects appear in
the LSE table. 
(15).Levels of Exposure Exposure levels for each health effect in
LSE tables are graphically displayed in the LSE figures. Exposure
levels are reported on the log scale “y” axis. Inhalation exposure
is reported in mg/m3 ppm and oral exposure is reported in mg/kg/day. 
(16). NOAEL In this example, 18r NOAEL is the critical end point for which
an intermediate inhalation exposure MRL is based. As you can see
from the LSE figure key, the open-circle symbol indicates a NOAEL
for the test species (rat). The key number 18 corresponds to the
entry in the LSE table. The dashed descending arrow indicates the
extrapolation from the exposure level of 3 ppm (see entry 18 in the
Table) to the MRL of 0.005 ppm (see footnote "b" in the LSE table). 
(17). CEL Key number 38r is one of three studies for which Cancer Effect
Levels(CELs) were derived. The diamond symbol refers to a CEL for
the test species (rat). The number 38 corresponds to the entry in e
the LSE table. 
A-4 
APPENDIX A 
(18). Estimated UDDer-Bound Human Cancer Risk Levels This is the
range associated with the upper-bound for lifetime cancer risk of 1
in 10,000 to 1 in 10,000,000. These risk levels are derive.d from
EPA's Human Health Assessment Group's upper-bound estimates of the
slope of the cancer dose response curve at low dose levels (q1*). 
(19). Key to LSE Figure The Key explains the abbreviations and





Chapter 2 (Section 2.4) 
Relevance to Public Health 
The Relevance to Public Health section provides a health effects summary
based on evaluations of existing toxicological, epidemiological, and
toxicokinetic information. This summary is designed to present
interpretive, weight-of-evidence discussions for human health end points
by addressing the following questions. 
1. What effects are known to occur in humans? 
2. What effects observed in animals are likely to be of concern to
humans? 
3. What exposure conditions are likely to be of concern to humans,
especially around hazardous waste sites? 
The section discusses health effects by end point. Human data are
presented first, then animal data. Both are organized by route of exposure
(inhalation, oral, and dermal) and by duration (acute, intermediate, and
chronic). In vitro data and data from parenteral routes (intramuscular,
intravenous, subcutaneous, etc.) are also considered in this section. If
data are located in the scientific literature, a table of genotoxicity
information is included. 
The carcinogenic potential of the profiled substance is qualitatively
evaluated, when appropriate, using existing toxicokinetic, genotoxic, and
carcinogenic data. ATSDR does not currently assess cancer potency or
perform cancer risk assessments. MRLs for noncancer end points if derived,
and the end points from which they were derived are indicated and
discussed in the appropriate section(s). 
Limitations to existing scientific literature that prevent a satisfactory
evaluation of the relevance to public health are identified in the
Identification of Data Needs section. 
Interpretation of Minimal Risk Levels 
Where sufficient toxicologic information was available, MRLs were derived.
MRLs are specific for route (inhalation or oral) and duration (acute,
intermediate, or chronic) of exposure. Ideally, MRLs can be derived from
all six exposure scenarios (e.g., Inhalation - acute, -intermediate, ­
chronic; Oral - acute, - intermediate, - chronic). These MRLs are not
meant to support regulatory action, but to aquainthealth professionals
with exposure levels at which adverse health effects are not expected to
occur in humans. They should help physicians and public health officials
determine the safety of a community living near a substance emission,
given the concentration of a contaminant in air or the estimated daily
dose received via food or water. MRLs are based largely on toxicological





MRL users should be familiar with the toxicological information on which
the number is based. Section 2.4, "Relevance to Public Health," contains
basic information known about the substance. Other sections such as 2.6,
"Interactions with Other Chemicals" and 2.7, "Populations that are
Unusually Susceptible" provide important supplemental information. 
MRL users should also understand the MRL derivation methodology. MRLs are
derived using a modified version of the risk assessment methodology used
by the Environmental Protection Agency (EPA) (Barnes and Dourson, 1988;
EPA 1989a) to derive reference doses (RfDs) for lifetime exposure. 
To derive an MRL, ATSDR generally selects the end point which, in its best
judgement, represents the most sensitive humanhealth effect for a given
exposure route and duration. ATSDR cannot make this judgement or derive an
MRL unless information (quantitative or qualitative) is available for all
potential effects (e.g., systemic, neurological, and developmental). In
order to compare NOAELs and LOAELs for specific end points, all inhalation
exposure levels are adjusted for 24hr exposures and all intermittent
exposures for inhalation and oral routes of intermediate and chronic
duration are adjusted for continous exposure (i.e., 7 days/week). If the
information and reliable quantitative data on the chosen end point are
available, ATSDR derives an MRL using the most sensitive species (when
information from multiple species is available) with the highest NOAEL
that does not exceed any adverse effect levels. The NOAEL is the most
suitable end point for deriving an MRL. When a NOAEL is not available, a
Less Serious LOAEL can be used to derive an MRL, and an uncertainty factor
(UF) of 10 is employed. MRLs are not derived from Serious LOAELs. 
Additional uncertainty factors of 10 each are used for human variability
to protect sensitive subpopulations (people who are most susceptible to
the health effects caused by the substance) and for interspecies
variability (extrapolation from animals to humans). In deriving an MRL,
these individual uncertainty factors are multiplied together. The product
is then divided into the adjusted inhalation concentration or oral dosage
selected from the study. Uncertainty factors used in developing a











A peer review panel was assembled for 2-butanone. The panel consisted of
the following members: Dr. Michael Norvell, Private Consultant, Ringoes,
New Jersey; Dr. Rolf Hartung, Department of Environmental and Industrial
Health, University of Michigan, Ann Arbor, Michigan; and Dr. Vincent
Garry, Director, Laboratory for Environmental Medicine and Pathology,
University of Minnesota, Minneapolis, Minnesota. These experts
collectively have knowledge of 2-butanone's physical and chemical
properties, toxicokinetics, key health end points, mechanisms of action,
human and animal exposure, and quantification of risk to humans. All
reviewers were selected in conformity with the conditions for peer review
specified in the Comprehensive Environmental Response, Compensation, and
Liability Act of 1986, Section 104. 
Scientists from the Agency for Toxic Substances and Disease Registry
(ATSDR) have reviewed the peer reviewers' comments and determined which
comments will be included in the profile. A listing of the peer reviewers'
comments not incorporated in the profile, with a brief explanation of the
rationale for their exclusion, exists as part of the administrative record
for this compound. A list of databases reviewed and a list of unpublished
documents cited are also included in the administrative record. 
The citation of the peer review panel should not be understood to imply
its approval of the profile's final content. The responsibility for the
content of this profile lies with the ATSDR. 
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